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Past studies have shown that the success of total joint replacements depends on the biocompatibility
of orthopaedic materials, which can be improved by modifying the implant surface. However, the
exact roles of these modifications and their effective mechanisms are poorly understood. The
objective of this study was to develop and evaluate a model system to investigate the impact of
nano-structured surfaces, produced by the ion beam-assisted deposition (IBAD) technique, on
biomarkers of osteointegration using an in vitro model. The IBAD technique was employed to
deposit zirconium oxide (ZrO2), Titanium oxide (TiO2), and Titanium (Ti) nano-films on glass or
Ti substrates. Essential cellular functions including adhesion, proliferation, differentiation, and
apoptosis of a human osteosarcoma cell line (SAOS-2) were compared on coated vs. uncoated
surfaces at both molecular and gene levels.
Our studies have resulted in several novel observations, including enhanced cell adhesion
on nano-coated surfaces assessed by the number of DAPI-stained cells along with monitoring cell
morphology (actin stress fiber remodeling at focal adhesion sites) on the surfaces using
immunofluorescence techniques. Similarly, we reported that IBAD nano-modifications increased
cell proliferation on nano-surfaces measured by mitochondrial dehydrogenase activity and a
nuclear cell proliferation-associated antigen. Moreover, enhanced cell differentiation on IBADproduced surfaces was determined by ALP activity and the rate of calcium deposition in alizarin
red assays that are in vitro indicators of the successful bone formation. In addition, programmed
cell death and necrosis assessed by annexin V staining and flow cytometry observed to be higher

on uncoated surfaces compared to nano-surfaces. Finally, there was a correlation between IBADmodifications and enhanced bone-associated gene expression at cell adhesion, proliferation, and
differentiation as assessed by polymerase chain reaction (PCR) techniques.
In summary, our studies using an in vitro model system showed that nano-coated surfaces
produced by the IBAD technique are superior to uncoated surfaces in supporting bone-cell
adhesion, proliferation, differentiation, and reducing apoptosis at both molecular and gene levels.
Therefore, increased osteoblast cellular functions and enhanced bone formation with stronger
attachments would be expected from these surfaces in bone-cell applications. In contrast, as
anticipated by design, polish uncoated metallic surfaces, e.g., cobalt-chromium inhibited such
interactions.
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CHAPTER ONE: INTRODUCTION

1.1
1.1.1

BACKGROUND
Joint and Related Problems
As defined in a medical dictionary (1), “a joint is a physical point where two or more bones

meet.” The main components of a joint are cartilage that covers the surface of the bones, fibrous
connective tissue that connects the bones together, and tendons that connect muscles to the bones.
Some joints are sealed by the synovial membrane that forms a joint capsule and is filled by synovial
fluid for lubrication. Joints are grouped based on their mobility as immovable, slightly movable, or
freely movable. Movable joints mainly include ball-and-socket joints, hinge joints, pivot joints, and
ellipsoidal joints. There are certain diseases affecting joints including osteoarthritis, rheumatoid
arthritis, gout, rheumatic fever, etc. Also, joints are subjected to injuries and inflammation based
on their location. Aging, continual wear, excess weight, and stress also cause irreversible damage
and cause joints to deteriorate. Besides pain, these problems limit ranges of motion and activities.
There are drugs that reduce inflammation based on the extent of the problem, but they may have
serious side effects such as bone loss, toxicities, or addiction. In addition, patients with end-stage
joint deterioration usually do not receive adequate relief or functional improvement from
medications and seek out a surgeon for operation options. Due to the progressive nature of their
disease, arthroscopy or osteotomy is not usually an option for these patients, and the ultimate
approach to cure the problem is joint replacement surgery (2).

1.1.2

Arthroplasty as a Solution
Arthroplasty or total joint replacement (TJR) is a major surgery that removes the damaged

joint and replaces it with a new, artificial one. Knees and hips are more often subjected to TJR, but
surgeries are not limited to them and include other joints such as shoulders, fingers, ankles, etc. In
2003 in the United States, 202,500 primary total hip arthroplasty (THA) and 402,100 primary total

2
knee arthroplasty (TKA) procedures were performed (3). Annually, more than 1.5 million TJRs are
performed globally, and the expected number for 2030 is expected to increase to 4 million (4).
Projected numbers for the United States, specifically, would be 3.48 million TKAs and 572,000
THAs by 2030 (5).

Figure 1-1: The projected number of primary THA and TKA procedures in the United States from 2005 to
2030 (3)

Based on increasing procedure volumes, Wilson et al. (6) estimated that the Medicare
expenditures of TJA would increase from $5 billion in 2006 to $50 billion in 2030 (5).
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Figure 1-2: Projected costs for primary THA and TKA procedures (7)

Although TJR can successfully restore patients’ mobility, currently the lifetime of
orthopedic implants are only 10–15 years (8). Therefore, 10-20% of surgeries will need revision
due to implant failure (3) resulting from infection, poor osseointegration, aseptic loosening, and
inflammation caused by wear particles. (4, 7). In 2003, in the United States, 36,000 THA revisions
and 32,700 TKA revisions were performed (3). As the number of primary procedures grows, the
number of revisions is also expected to expand (2).
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Figure 1-3: The projected number of revision THA and TKA procedures in the United States from 2005 to
2030 (3)

These projections are based on historical data. However, improvements in implant
technology or orthopaedic treatments have the potential to reduce the need for revision surgeries
(3). Therefore, improving outcomes by developing better technologies for arthroplasty can make a
substantial savings of health care dollars and significantly reduce future Medicare costs.

1.1.3

Biological Events Happening after Surgery
When the implant is placed in the body, a series of events occur. First of all, there is an

interaction between the implant surface and bloodstream that leads to an exchange of proteins and
ligands. The subsequent healing process that starts around the implant has three phases,
osteoconduction, bone formation, and bone remodeling. Osteoconduction starts with platelet
activation that results in migration of osteogenic cells to the implant surface. Next, the osteogenic
cells differentiate to bone-forming cells (osteoblasts), which start to secrete the matrix and

5
mineralize it. Lastly, bone remodeling happens, which is a slow process and needs multiple cycles
to give bone-implant complexes the appropriate mechanical strength (9). However, this healing
process does not always happen, and sometimes the host system forms a fibrous capsule to protect
itself from the foreign body (implant); this is termed fibrosis. This capsule cannot remove dead
cells (apoptotic or necrotic cells) and these may lead to inflammation. Also, matrices generated by
fibroblasts are entirely different from bone matrix (10).

Figure 1-4: Cellular events during the implant healing process (11)

Implant osseointegration properties directly affect the outcomes of the healing processes.
Also, implant surface properties such as chemical properties, physical properties, roughness, and
hydrophilicity (wettability) directly influence the rate and quality of the healing processes (9). Note
that, effective osseointegration is essential to fixation of that part of the prosthesis in contact with
bone and is not required or even desirable for the articulating surfaces of the prosthesis that are
designed to minimize the cellular adhesion.
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Figure 1-5: The implant healing process reflects surface composition and surface roughness that influence
osteoblasts responses (11)

1.1.4

Implant Properties
The properties that determine if a material is suitable to be used as an implant are

mechanical and chemical, as listed below:
Modulus of elasticity: The elasticity module of the implant material should be equivalent to that
of bone to ensure a uniform stress distribution (12).
Tensile, compressive and shear strength: High tensile, compressive and shear strengths prevent
the transfer of fractions and lower stress to the bone (12).
Yield and fatigue strength: High yield and fatigue strengths protect the implant from fracture
under cyclic loading (12).
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Hardness and Toughness (wear resistance): Increased hardness decreases wear, and increased
toughness prevents fractures (12).
Biocompatibility: implant materials should be non-toxic and must not trigger inflammatory or
allergic responses (13).
Surface energy and tension: This determines implant wettability and affects protein absorption
(increased osteoblast adhesion is expected from hydrophilic surfaces) (9, 12).
Surface roughness: Increased roughness provides extra surface area for cells to attach (12). Microand nano-roughness are mainly used for implants and are believed to affect wound healing and
osseointegration (9).
Corrosion resistance: Higher corrosion resistance equals to lower ion transfer from the implant
surface to the surrounding environment (12).

Osseointegration: Integration of implant surface with surrounding bone and tissue is necessary for
the non-articular component of the prosthesis (13).
Thus the development of implants with optimal chemical and mechanical properties,
especially corrosion and wear resistance, is significant for the longevity of the implant.

1.2
1.2.1

PROBLEM STATEMENT
Implant Failures
Like all biomedical devices, implants can also fail over time, because of trauma, chronic

joint disease, prosthetic loosening, and infection of the joint. Joint replacement is usually a success,
but possible problems occur, such as infection or aseptic loosening.
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Infection: Areas in the wound, or around the new joint, may get infected. It may happen
during surgery, hospital stay, or after discharge. It may even occur years later. Minor infections in
the wound are usually treated with drugs. Deep infections may need a second operation to treat the
infection or replace the joint (revision surgery).

Figure 1-6: The projected number of infected revision THA and TKA procedures (7)

Aseptic loosening: The new joint may loosen, causing pain. If the loosening is very
significant, another operation may be needed. Aseptic loosening can be explained by four concepts,
including wear particle disease, interface sealing effects, hydrostatic fluid pressure concepts, and
the bacterial endotoxin theory (14).
Wear particles: Some wear can be found in all joint replacements. The amount, type, and
size of wear particles depend on the particles materials, the orientation, and the position of the joint.
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These particles activate macrophages and cause secretion of proinflammatory enzymes that may
lead monocytes/macrophages to differentiate to bone-resorbing osteoclasts (14). Characteristics of
wear particles such as size, shape, material and amount, directly affect this procedure. For example,
only particles from 0.3 to 10 μm can be phagocytosed by macrophages and activate them, thus
increased proinflammatory reactions would be expected from these size-range particles (14).

1.2.2

Current Implant Materials
The artificial joint known as the prosthesis is usually made of metal or a combination of

metals and plastic. It is usually cemented into place, and bone adjacent will grow into it.
Polymers: Polymers are reported to be biologically tolerable substances and are selected
for implant technology because their physical characteristic can be easily altered and
microscopically evaluated. They show fibrous connective tissue attachments, and unlike metals,
they do not generate microwaves or electrolytic currents. However, there are some disadvantages,
such as low-quality mechanical properties, low adhesion to living tissues and adverse immunologic
reactions (12). Polyethylene, which is commonly used, showed low wear particle production (7 %
of the revisions related to PE wear), and its fracture is rare (15).
Stainless steel: Stainless steel is used for iron-based alloys containing chromium and
sometimes nickel. Stainless steel is readily available with low cost that possesses acceptable
biocompatibility and suitable hardness and corrosion resistance. However, it has low fatigue
behavior that makes it improper for long-term implants. Also, excessive iron released from the
implant may cause reactions in blood or damage cellular components. Moreover, added nickel is
toxic to the human body (16).
Cobalt-chromium: CoCr alloys are among the oldest implant materials and orthopedic
implants used to be made out of cobalt, chromium, molybdenum, and nickel (17). Cobalt provides
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a continuous phase for basic properties, chromium is added to increase corrosion resistance via its
oxide surface, molybdenum is added for higher strength and corrosion resistance, and nickel
enhances mechanical properties (12). The articular surfaces is usually polished.
Because of the high fatigue resistance, it is an excellent choice for TJR although CoCr
alloys are expensive and difficult to machine (16). The primary concerns with CoCr are wear
particles, stress shielding effects because of the high Young’s modulus, metal toxicity, and the risk
of hypersensitivity that may cause systemic allergic reactions and inflammation in the host body
(16, 18).
Titanium: Ti is biocompatible because of the thin oxide layer on its surface. Ti alloys also
show high strength and good corrosion resistance. In Ti alloys, Iron provides corrosion resistance,
aluminum provides increased strength and decreased density, and vanadium prevents corrosion
(12). As for disadvantages, they have low wear resistance properties, and vanadium used in Ti alloy
is cytotoxic. Also, there is no proper equivalent elastic modulus between Ti implants and the bones,
which passes stress to the bone and is associated with bone resorption (19).

Figure 1-7: Properties of stainless steel, CoCr, and Ti implants (84)

Magnesium: Mg has high malleability and can be tolerated by the body at relatively high
levels, thus it has been used mainly in pediatric orthopaedics or devices for the internal fixations.
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However, it is highly corrosive and absorbable with low rigidity and toughness that limits its
application (17).
Ceramics: Zirconium is a less allergenic material and is used as ZrO2, also known as
zirconia, by the implants industry. Ceramic implants are known for good osseointegration, strength,
and physical properties (12). ZrO2 knee implants produce less PE wear compared to CoCr, but the
surface roughness of ZrO2 is lower than that CoCr (18).
Tantalum: Ta has some common characteristics with Ti such as high biocompatibility,
flexibility, and corrosion resistance, but it is costly. Also, because Ta is highly porous, fracturing
can be an issue (17).

1.2.3

Surface Modifications as a Solution
To facilitate healing processes and reduce the rejection rates, osseointegration and

osteoinduction of implant materials should be improved (20). Improving the bone-implant interface
can be achieved via physical or chemical techniques (10). The physical methods modify the implant
surface by modifying surface morphology, topography, and organization, via different methods
such as etching, plasma spraying, sintering powders, grit-blasting, anodization, and
machining/micro-machining (10, 20). The rationale behind physical approaches is increasing
surface roughness that provides higher surface energy levels that improve protein adsorption and
osteoblast functions (10). It has been shown that micro-topography and nano-topography influence
cell adherence and spreading. The chemical methods create a bioactive surface by applying
different coatings onto the implant layer via biochemical and physicochemical techniques. The only
difference between biochemical and physicochemical coatings is the use of organic materials
(growth factors, peptides, or enzymes) or inorganic (i.e., calcium phosphate) materials. Some
modifications may also combine both physical and chemical coatings (10).
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Figure 1-8: Biomedical coating for implants (21)

Among the techniques that are used to improve bioactivity and biocompatibility, ion beam
techniques including ion beam sputtering deposition (IBSD) and ion beam assisted deposition
(IBAD) can be beneficial. These techniques are used to deposit thin and homogeneous films on
the metallic substrates with high adhesive strength. The only difference between the IBSD and
IBAD is ion bombardment in the IBAD technique that leads to a higher adhesive strength (21).
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Figure 1-9: Schematic of (a) IBSD and (b) IBAD (22)

It has been shown that by controlling IBAD processing parameters, specifically the ion
beam current density, and the coating chemical composition can be controlled. Therefore, IBAD
is an excellent technique for implant coating because of the high adhesive strength, low substrate
temperature, high reproducibility, and controllability of microstructure and chemical composition
(21).

1.3
1.3.1

RESEARCH QUESTIONS AND BACKGROUND OF THE PROJECT
DESIGN
Surfaces with Increased Biocompatibility, Resistance to Wear, and Antiinfective Properties
Nano-technology is defined by the National Aeronautics and Space Administration as “the

creation of functional materials, devices, and systems through control of matter on the nanometer
length scale (1–100 nm), and exploitation of novel phenomena and properties (physical, chemical,
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and biological) at that length scale” (p. 187). Nano-technology involves materials with nano-sized
topography that plays an essential role in the protein adsorption, osteoblasts adhesion, and
osseointegration. However, producing such surfaces are challenging (9). The nano-technology
laboratory of the Department of Orthopaedic Surgery and Rehabilitation at the University of
Nebraska Medical Center (UNMC) was inaugurated in 2004 with the core technology of IBAD to
produce nano-crystalline coatings for reducing the wear of artificial orthopaedics implants. In 2008,
Namavar et al. reported transparent nano-crystalline ZrO2 films possessing combined properties of
hardness and wetting behavior to benefit wear reduction and biomedical applications (22). To
evaluate the osseointegrative properties of the ZrO2 coatings, they performed a series of biological
experiments including alamar blue assays and direct cell counting methods (using a
hemocytometer) to determine the growth of mesenchymal stromal cells (OMA-AD) on different
nano-engineered surfaces. The in vitro experimental results indicated that the nano-engineered
ZrO2 was superior in supporting adhesion, and proliferation (23).

Figure 1-10: OMA-AD growth on nano-crystalline ZrO2 compared with HA and CoCrMo (23)
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They also performed a comparative analysis of absorption energies of fibronectin (FN)
fragments using quantum mechanical calculations and Monte Carlo simulations on different
surfaces to elucidate why cells attached more effectively to ZrO2 nano-structures (23-25). During
their ongoing search for durable coatings to promote bone marrow stromal cell growth, they also
investigate if the IBAD-produced coatings could prevent biofilm formation and the preliminary
results showed reduced staphylococcus aureus attachment and growth on nano-structures (26).
Limited in vivo experiments indicated that IBAD nano-structured surfaces not only did not elicit
any excessive inflammatory responses that inhibited new bone formation but also counteracted
deficiencies in converting woven bone to mature bone (27). Based on these preliminary data, Dr. F
Namavar (emeritus professor in the Department of Orthopaedic Surgery and an expert in material
sciences and nano-technology) proposed the idea of producing “triple smart” surfaces for implants
that possess optimized wear resistance, anti-infective and osseointegrative properties.

The author joined the team in 2012 as a volunteer and started her Ph.D. program the same
year. This research proposal was focused on one aspect of triple smart surfaces, i.e., their
osseointegration. The plan was to develop a model system to study osteoblast functions including
cell adhesion, proliferation, and differentiation on different nano-sample and micro-sample
surfaces to investigate the differences between nano-materials vs. bulk materials mainly, along with
the effects of coating chemistry and substrates on the outcomes of bone-forming (osteogenic) cells
behaviors.

1.3.2

OMA-AD Stem Cells
Namavar et al. used a murine mesenchymal stem cell (MSC) cell line OMA-AD for the in

vitro experiments to determine the effect of nano-structures coatings on cell growth. OMA-AD was
derived from the bone marrow of a female C57Bl/6 mouse by repeated trypsinization of the
adherent layer of a long-term bone marrow culture (28). OMA-AD cells represent a spontaneously
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immortalized mouse MSC line and are capable of differentiating to all of the primary cell lineages
of mesenchymal (connective) tissue lineages such as osteoblasts. These cells also supported
primitive mouse hematopoietic stem cells and hematopoietic cells in culture (28). Obviously, using
them is more efficient and less costly than primary cells. However, the cell line was generated from
mice, thus there are potential interspecies differences, genomic differences and cell phenotypes that
are sensitive to age and site of isolation factors (29). Also, OMA-AD cells are stem cells and their
application in experiments needs extra time for differentiation into osteoblasts. Therefore, after a
comprehensive search, the author decided to use SAOS-2 cells instead. These cells are well
differentiated human osteosarcoma cell lines, showing mature osteoblast phenotypes (for more
details see Chapter 2).

1.4
1.4.1

LIMITATIONS
Standardization of Methods to Test and Compare Surfaces
All new materials or new coatings for implants first need in vitro and later, in vivo

evaluations before they seek approval for clinical trials. These tests are generally used to compare
the new surfaces with known and FDA approved orthopaedic materials in order to investigate any
enhanced properties. In vitro experiments are mainly focused on evaluating cell morphology,
adhesion, migration, proliferation, differentiation, and gene expression. Although these are
considered the first steps to monitor biological events for the new surfaces, they cannot provide an
evaluation as complete as in vivo experiments. The bone-implant environment is dynamic and only
animal models, and later clinical trials can confirm the efficiency of new implant surfaces (9).
Therefore, it was initially necessary to test nano-surfaces in vitro. Namavar’s team had been using
limited in vitro techniques (alamar blue and FN staining) to show differences between nanosurfaces with other orthopedic materials. Their focus was on initial adhesion and proliferation, and
mainly, they were interested in FN effects. However, the new experimental design proposed for
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this study was to develop and evaluate a model system that investigates all essential cellular events
including adhesion, proliferation, cell morphology, apoptosis, necrosis, and differentiation. The
techniques used to test these features are in development and currently, there is no standard for
such analyses. A comprehensive research plan had to be devised and modified to identify the best
techniques to establish the criteria necessary to achieve this objective. The methods, results, and
conclusions of this research are described following.

1.5

DISSERTATION ORGANIZATION
This dissertation is organized into six chapters as follows:
 Chapter 1: presents background information, the statement of problems, research questions,
and background to project design, methods limitations, and organization of this dissertation.
 Chapter 2: presents methods for designing and implementing tools used in the experiments
 Chapter 3: provides the data from the first paper
 Chapter 4: provides the data from the second paper
 Chapter 5: provides the data from the third paper
 Chapter 6: is a summary of the conclusions of papers and general discussion of all of the
studies along with suggestions for future work.
Chapters 3, 4, and 5 are duplication of published papers during this study.
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2

CHAPTER TWO: MATERIAL AND METHODS

2.1
2.1.1

NANO-FABRICATION
IBAD Technology
Depositing thin metallic or ceramic films on different surfaces was performed by the IBAD

technique that allows designing and engineering nano-crystalline coatings with distinct structures,
chemistry, and morphology. The IBAD combined evaporation with concurrent ion beam
bombardment (e.g., N, O, and Ar) in a high vacuum stainless steel water-cooled vacuum chamber.
The base pressure was about 5*10-8 torr, and the operating pressure was in the range of 10-4 to 106

torr. The IBAD was equipped with an RF 12 cm Ion gun that generated a maximum current of

500 mA at 1500 eV ion energies, an electron-beam evaporation source that provided evaporation
temperature up to 2500°C, a residual gas analyzer, and a 10 kW electron gun with a programmable
sweep multi-pocket four electron beam evaporation source. During the process, a vapor flux of
atoms was generated with an electron beam. Ions of a particular gas simultaneously were extracted
from plasma, and the bombardment of these energetic ions was employed, like a hammer, to stitch
nano-films to the substrate. Ion bombardment, the critical factor in controlling film properties,
along with other processing properties including coating material, evaporation rate, ion species,
ion energy, and ion beam current density, substrate temperature, and orientation, made the IBAD
technique capable of producing materials with exceptional chemical, physical, mechanical
properties.
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Figure 2-1: Schematic of the IBAD system

2.1.2

Chemistry of Coatings
IBAD is capable of producing different nano-films on surfaces. Candidates for biomedical

applications are nano-crystalline coatings of pure cubic ZrO2, TiO2, Ta oxides, cerium oxides, Ti
nitrides, aluminum oxides, and silver. Based on the preliminary data, for this study, pure cubic ZrO2
and Ti were chosen.

2.1.3

Nano-crystalline Properties and Tests Performed on Surfaces (Wettability and
Roughness)
Transparent nano-crystalline cubic ZrO2 films were produced by IBAD with hardness as

high as 16 GPa and a bulk modulus of 239 (12 GPa). Source material for deposition was 99.7%
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pure ZrO2 with a monoclinic crystal structure, and evaporation rate ranged from 1 to 4 Å/s, ion
energy from 0 to 600 eV, ion current density from 0 to 500 μA/cm2, and the substrate temperature
from room to 550°C. The ion beam was compromised of O, N, Ar ions, or mixtures and the average
nano-crystalline grain size increased from 5 to 70 nm as the deposition temperature increased from
room temperature to 550°C. These ZrO2 films were maximally wettable by water and demonstrated
from zero to several degrees contact angles with adequate surface energy 22–24 of 82 dynes/cm
(22).

Figure 2-2: a) Contact angle of cubic ZrO2 that indicated a contact angle of about 5° for deionized water (b) AFM
of the same sample measured the roughness of about 7 nm (22)

Source material for IBAD TiO2 films was 99.9 % pure rutile TiO2 and evaporation rate
ranged from 2 to 3 Å/sec, ion energy from 100-120 eV, and the substrate temperature from room
to 610°C. Ion beam was compromised of O, N, or Ar and the thickness of the deposited films was
about 1 μm. The IBAD TiO2 films made with Ar, O, and N ion beams showed roughness values of
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64.4 nm, 20.4 nm, and 19.4 nm relatively. Different ranges of grain sizes were obtained with
different chemical ion beams in the IBAD process. TiO2 films made with Ar, O, and N ion beams
have roughness values of 64.4 nm, 20.4 nm, and 19.4 nm respectively. All these values showed
greater roughness than the usual films made with other techniques (30).

Argon
RMS
64.4 nm

Oxygen
RMS
20.4 nm

Nitrogen
RMS
19.4 nm

Figure 2-3: Morphology of nano-crystalline TiO2 determined by atomic force microscopy (AFM) for a 5micron scan size. IBAD-produced TiO2 films showed different roughness by varying ion species (30)

2.1.4

Substrate Materials
Glass and Ti were used as substrates for nano-coating. Ti is a material with a microstructure

that is used for orthopaedic purposes because of its enhanced biocompatibility. Glass substrates
were used to eliminate inherent surface properties of metal surfaces, allowing a focus solely on the
specific nano-coating properties. ZrO2 deposited onto glass and Ti and TiO2 deposited on Ti were
used in this study.
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2.1-5 Samples preparation
Both nano-coated surfaces and control glass surfaces were cut into 10 mm by 10 mm
squares (area = 100 mm2), and CoCr samples were cut into disks with 12.7 mm diameter (area =
127 mm2), sonicated for 1 to 2 hours in a 50:50 acetone:methanol mixture, wrapped in aluminum
foil and autoclaved to ensure clean, sterile surfaces for cell culture studies.

2.2
2.2.1

CELL LINES
Osteosarcoma Cell Line
SAOS-2 is a human osteosarcoma cell line isolated from an 11-year old Caucasian female

in 1975 and was selected for use in the model system of osteoblast functions.

Figure 2-4: SAOS-2 cells in culture

These cells show a mature osteoblast phenotype and production of mineralized matrixes
and high levels of alkaline phosphatase (ALP) activity are major characteristic (29, 31). They are

23
able to form a calcified matrix typical of woven bone, and their synthesized collagen structures and
cytokine and growth factor production are similar to human primary normal osteoblast cells (29).
These properties make them a chosen model for studies of osteoblast functions. However, they are
osteosarcoma cells and were derived from malignant bone tumor thus their chromosomal
alterations may lead to abnormal molecular and cellular functions that may not mirror the whole
range of osteoblast phenotypic properties (29, 32). The SAOS-2 cells were obtained from the
ATCC and based on their protocol were, cultured in McCoy’s 5A medium, supplemented with 15%
heat-inactivated FBS and 1% gentamycin in a humidified 5% CO2 atmosphere at 37°C. The
differentiation medium, used for ALP and PCR experiments, employed the same medium as above,
supplemented with 0.3 mM ascorbic acid and 10 mM glycerol phosphate.

2.3

ADHESION
For quantifying adherent cells and morphology of focal adhesions, SAOS-2 cells at a

density of 100,000 cells per 2 ml were cultured on surface samples in 12-well plates for 2 hours.
The medium was removed from the samples, washed with PBS/1%BSA, transferred to fresh 12well plates, 2 ml of fresh medium was added, and incubated for 24-48 hours. Samples were washed
with 1x PBS containing 1% BSA, fixed with 1 ml of 4% formaldehyde for 10 minutes, and
permeabilized with 1 ml of 0.1% Triton-X-100 for 5 minutes, all at room temperature. Samples
were stained first with actin (5 µl of stock solution into 200 µl PBS/1%BSA, Alexa Fluor 546
Phalloidin) for 30 minutes and rinsed with PBS 3 times for 5 minutes at room temperature. DAPI
(1 ml of a 300 nM stock solution of 4', 6- diamidino-2-phenylindole dihydrochloride in PBS per
sample) was added to each sample for 5 minutes in the dark at room temperature. Between all steps
above, cells were washed twice with PBS/1% BSA buffer. Samples were fixed to the slides and
coverslips were attached with Fluormount-G. From each sample, 10 digital images were randomly
taken with a Nikon camera using a planar 10x/0.25 objective. The morphology of focal adhesions
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and actin of SAOS-2 cells cultured on the samples were characterized by microscopy after
immunofluorescent staining and random images from samples were analyzed. DAPI-stained cells
were automatically counted after single-channel image segmentation and binary masking. Cells
were quantified using ImageJ software (IJ 1.45 m) and Metamorph software, and data were
expressed as the average number of DAPI-stained cells in 15 random fields captured at 10x
magnification.

2.4
2.4.1

PROLIFERATION
Metabolic Activity
As an indicator of cell viability and proliferation, the metabolic activity of SAOS-2 cells

on coated and uncoated surfaces was determined using a MTS assay. The original form of this
assay was described by Mosmann and improved by several other investigators subsequently (3337). Our study employed the method described as follows. Briefly, 500,000/ml cell with 2 ml of
suspension were cultured as outlined above on different surfaces. After 24 hours, all samples were
transferred to a fresh 12-well plate, fresh medium was added, and incubated for 3 more days. At
day 4 after plating, the medium was removed from the samples, 200 µl of fresh medium, and 40 µl
MTS dye solution was added to each sample. The plates were incubated in a CO2 incubator at 37°C
for 3 hours. After this incubation period, 100 µl of supernatant was transferred into each well of a
96-well plate and absorbance of the MTS formazan dye product was measured photometrically at
490 nm using an Infinite M200 plate reader.
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Figure 2-5: MTS plate after the incubation period, ready for measuring by a plate reader

The cells in each well were stained with DAPI and visualized at 10x by fluorescence
microscopy as described in the cell counting section.

2.4.2

Ki-67
In order to compare osteosarcoma cell proliferation on different surfaces, the Ki-67 assay

was applied using PE mouse anti-human Ki-67 Set (RUO) from Biosciences (38). Ki-67, a nuclear
cell proliferation-associated antigen, expressed by all human proliferating cells, can be recognized
at all stages of the cell cycle (late G1, S, M, and G2 phases) except for G0 phase (39, 40).
Approximately 30 flasks of cells were harvested at 50% confluency using trypsin, and detached
cells were adjusted to 500,000 cells per 2 ml (250,000/ml), 3 samples of each surface were placed
in a 12-well plate, and each sample was seeded with 500,000 cells (2 ml for each well), and
incubated for 24 hours. After 24 hours, samples were transferred to a fresh 12-well plate; fresh
medium was added and incubated for 3 more days. At day 4 after plating, samples were washed
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with 1 ml PBS once, 500 µl of accutase were added to each well (see Appendix for details of
optimization of this procedure), and incubated for 10 minutes at room temperature. After 10
minutes, 2 ml of medium was added to the each well, detached cells were collected in separate 15ml conical tubes, centrifuged at 200 g for 5 minutes, the supernatant was discarded, 5 ml of cold
70% - 80% ethanol was added drop by drop onto the cell pellet in each tube, mixed well and were
incubated at -20°C for 24 hours. For Ki-67 staining by flow cytometry,10 ml wash buffer (PBS
with 1% FBS, 0.09% NaN3 pH7.2) was added to the fixed cells in each tube, centrifuged for 5
minutes at 200 g and supernatant was aspirated. Another wash was performed as described, cells
were resuspended in 100 µl wash buffer, 20 μl of antibody was added into the tubes, and mixed
gently. Tubes were incubated at room temperature for 30 minutes in the dark, washed with 2 ml of
PBS washing buffer, centrifuged at 200 g for 5 minutes, and 0.5 ml of PBS wash buffer was added
into each tube. The samples were analyzed by FACS.

Figure 2-6: An example of the Ki-67 flow cytometry batch analysis
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2.5
2.5.1

DIFFERENTIATION
Alizarin Red
To determine calcium deposition, SAOS-2 cells were cultured as described previously,

incubated on the different surfaces for 7 and 14 days in 24-well plates, and alizarin red staining was
performed following the standard protocol as described in the Osteogenesis Assay Kit (ECM815,
Millipore). After removing medium from the samples and rinsing with PBS, samples were
transferred to fresh plates and fixed with 10% formaldehyde at room temperature for 15 minutes.
Samples were rinsed 3 times with de-ionized water, 1 ml alizarin red stain solution was added to
each well, followed by incubation at room temperature for 20 minutes. Excess dye was removed
by 4 washes with de-ionized water, 400 µl of 10% acetic acid was added to each well, the plates
were incubated for 30 minutes with shaking, and the mixtures were transferred to 1.5-ml centrifuge
tubes. To remove the cell monolayer, samples were vortexed for 30 seconds and then incubated at
85°C for 10 minutes in a block heater. Tubes were placed on ice for 5 minutes and then centrifuged
at 20,000 g for 15 minutes. A 400-µl portion of the supernatant was transferred to a fresh 1.5-ml
centrifuge tube and the pH was neutralized with 150 μl of 10% ammonium hydroxide (pH 4.1-4.5).
Finally, 150 µl of the mixture in each tube was transferred to one well of a 96-well plate, and the
absorbance at 405 nm was quantified.

2.5.2

Bone-specific Alkaline Phosphatase
In order to compare osteosarcoma cell differentiation on the different surfaces, an alkaline

phosphatase (ALP) assay was used. A bone-specific isoform of ALP is found on the cell surface
of osteoblasts that are responsible for the synthesis of the new bone matrix and its mineralization.
The SensoLytepNPP ALP assay kit can detect ALP by ELISA using colorimetric pNPP (pNitrophenyl phosphate) phosphatase substrate at absorbance 405 nm. The study employed the ALP
assay as described by Lin and modified as follows (41). About 30 flasks of cells were harvested at
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50% confluency using trypsin, and detached cells were brought to the 500,000 cells per 2 ml
(250,000/ml) density, 3 samples of each surface were placed in a 12-well plate, and each sample
was seeded with 500,000 cells (2 ml for each well), and incubated for 24 hours. After 24 hours,
samples were transferred to a fresh 12-well plate. Fresh medium was added and incubated for
another day. At day 2 after plating, differentiating medium was added and incubated for 3 more
days. At day 5 after plating, 1X assay buffer, pNPP ALP substrate working solution, and Triton X
buffer were prepared according to the manufacturer's instructions. To prepare cell extracts, 500 µl
of the Triton X buffer was added to each sample, cell suspensions were incubated the at 4°C for 10
minutes under agitation (100 rpm), collected in a microcentrifuge tube, centrifuged at 2500 g for
10 minutes at 4°C, and the supernatant was collected for ALP assay.

Figure 2-7: Samples for an ALP experiment, 5 days after plating

To detect ALP activity, 100 µL of pNPP substrate working solution was added into each
well, mixed by gently shaking the plate for 30 seconds, and incubated at room temperature for 60
minutes in the dark. After the incubation period, 50 µL of stop solution was added into each well,
and the absorbance was measured at 405 nm using Epoch microplate spectrophotometer
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Figure 2-8: ALP plate after the incubation period, ready for measuring by a plate reader

ALP activity of cell lysates was extrapolated from the ALP standard curve, and the ALP
activity was normalized according to the number of cells in the cell lysates using a BCA protein
assay. This assay is based on bicinchoninic acid (BCA) for the colorimetric detection and
quantitation of total protein. One cuprous ion forms a complex with two BCA molecules, producing
a purple-colored, water-soluble complex that absorbs light at 562 nm. The absorbance data were
plotted against the standard curve to calculate the concentration of protein in samples.

2.6

APOPTOSIS
Cell death can be classified into non-programmed (in injury or trauma) and programmed

(in apoptosis and autophagy) groups, and losing plasma membrane integrity is the first element to
determine the nature of the cell death. In the early stages of apoptosis, phosphatidylserine (PS) is
translocated from the inner to the outer layer of the cytoplasmic membrane. This translocation
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marks the cell for recognition and phagocytosis by macrophages and other cells (42). To compare
programmed cell death of SAOS-2 cells on different surfaces, an annexin V kit with PI (propidium
iodide) staining was used. Annexin V is a protein with high affinity for PS, which is labeled with
a fluorophore. This kit also includes red fluorescent propidium iodide (PI) nucleic acid binding dye
that is impermeable to live cells and apoptotic cells, but stains dead cells with red fluorescence.
Therefore, apoptotic cells show green fluorescence, dead cells show red and green fluorescence,
and live cells show little or no fluorescence.

Figure 2-9: Apoptosis Detection Assay (83)

These populations can be distinguished using a flow cytometer with a 488 nm excitation
laser. The assay was mentioned by Koopman and have been optimized by Invitrogen (43, 44).
Some modifications applied for use with our in vitro model mentioned as follows. Approximately
30 flasks of cells were harvested at 50% confluency using trypsin and the detached cells were
adjusted to 1,000,000 cells per 2 ml (500,000/ml), 3 samples of each surface were placed in a 12well plate and each sample was seeded with 1,000,000 cells (2 ml for each well), and incubated for
24 hours. After 24 hours, samples were transferred to a fresh 12-well plate; fresh medium was
added and incubated for 3 more days. At day 4 after plating, 1X annexin-binding buffer, and PI
working solution were prepared based on the manufacturer's protocol. Subsequently, samples were
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washed with 1 ml PBS, 500 µl of accutase was added to each well and incubated for 10 minutes at
room temperature. After 10 minutes, 2 ml of medium was added to each well; detached cells were
collected in separate 15-ml conical tubes, centrifuged at 200 g for 5 minutes, supernatant was
discarded, cells were washed with cold PBS, and resuspended in 1X annexin-binding buffer, and 5
µL alexa fluor 488 annexin V and 1 µL 100 µg/mL PI working solution were added to each 100
µL of cell suspension and incubated at room temperature for 15 minutes in the dark. After the
incubation period, 400 µL 1X annexin-binding buffer was added to the samples, mixed gently, and
kept on ice for analysis within 1 hour, by flow cytometry, measuring the fluorescence emission at
530 nm and 575 nm or equivalent, using 488 nm excitation. From each sample, 10,000 events were
collected, and the population was separated into three groups: live cells (little or no fluorescence),
apoptotic cells (green fluorescence), and dead cells (red and green fluorescence). Data are
expressed as the average percent viability. Controls that were used included unstained cells, cells
stained with annexin V conjugate only (no PI), and cells stained with PI only (no annexin V
conjugate).
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Figure 2-10: Flow cytometric analysis of the SAOS-2 cells using apoptosis detection kit

2.7

RNA EXTRACTION / QUANTITATIVE REAL-TIME PCR
In order to determine the responses of human osteoblast cells to implant surfaces, the gene

expression profiles as modified by the cell to surface interactions such as initial adhesion,
proliferation, and differentiation, were measured using PCR techniques. RNA from cells cultured
on the various surfaces was extracted and evaluated by real-time PCR for the osteogenic markers
and matrix proteins listed in Table 2-1. This table includes transcription factors and osteoblastic
marker genes that are involved in osteoblast adhesion, growth, and differentiation (45-48).
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Table 2-1: List of genes used for PCR experiment
Target Gene

Abbreviation

Implication

Fibronectin

EGFLAM

Promoting cell attachment and migration

Ki-67

MKI67

Proliferation marker

RUNX 2

RUNX 2

Early osteoblastic transcription factor

Alkaline phosphatase

ALPL

Marker for bone mineralization (initial stage)

Osteopontin

SPP1

Marker for middle stage osteogenic differentiation

Osterix

SP7

Transcription factor in osteoblast differentiation

Bone morphogenetic protein 2

BMP2

Stimulates the production of bone

GAPDH

GAPDH

Control (housekeeping gene)

About 130 flasks of cells were harvested at 50% confluency using trypsin and detached
cells were adjusted to 500,000 cells per 2 ml (250,000/ml) density. For each adhesion, proliferation,
and differentiation set, 3 samples of each surface were placed in separate 12-well plates. Each
sample was seeded with 500,000 cells (2 ml for each well) and incubated for 24 hours. After 24
hours, the adhesion set samples were harvested, but the samples from proliferation and
differentiation samples were transferred to fresh 12-well plates, and fresh medium was added. The
proliferation samples were incubated for 3 more days and harvested on day 4. For differentiation
samples, at day 2 after plating, differentiation medium was added, samples were incubated for 3
more days, and were harvested at day 5 after plating. Cells were harvested using accutase as
previously described. Detached cells were placed in separate centrifuge tubes, centrifuged at 14,000
rpm for 5 minutes, and the supernatant was discarded. To isolate RNA, QIAGEN RNeasy mini kits
were used. Cells were resuspended in 350μL RLT buffer, vortexed for 5 seconds, pipetted onto a
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QIAshredder spin column, centrifuged at 14,000 rpm for 2 minutes and the lysate was transferred
to a gDNA eliminator spin column, centrifuged at 10,000 rpm for 30 seconds, and the flowthrough
was saved. Then, 350μL of 70% ethanol was added to the lysate, mixed well by pipetting, 700μL
of the sample was applied to an RNeasy mini column, centrifuged at 10,000 rpm for 20 seconds
and the flowthrough was discarded. Next, 700μL Buffer RW1 was added to the column, centrifuged
at 10,000 for 20 seconds, the flowthrough was discarded, and columns were transferred to new 2mL collection tubes. Subsequently, 500μL Buffer RPE was pipetted onto the column, centrifuge at
10,000 for 20 seconds, flowthrough was discarded, 500 μL buffer RPE was added to the column,
centrifuged at 10,000 rpm for 2 minutes. Columns were transferred to a new 1.5-mL collection
tube, 50μL RNase-free water was pipetted onto the column membrane and centrifuged at 10,000
rpm for 1 minute. RNA quantification was performed at this stage to confirm successful isolation.
For reverse transcription, cDNA master mix was made by adding 6 µl of 10x RT Buffer, 6 µl of
10x Random Primer, 3 µl of Multiscribe, 2.4 µl of 25x dNTPs, and 12.6 µl of nuclease-free water
per reaction. Then, 30 µl of RT master mix and 30 µl of each RNA sample were added in separate
centrifuge tubes, incubated at room temperature for 10 minutes in an incubator at 37°C for 2 hours,
and then on a heat block at 85°C for 5 minutes, and stored at 4°C in the dark. To achieve the desired
volume for each PCR, 70 µl of nuclease-free water was added to each cDNA sample. The PCR
master mix for each sample and each primer was generated by adding 50 µl of TaqMan Master
Mix, 5 µl of specific primer, 10 µl of cDNA Sample, and 35 µl of Nuclease-free water to a small
tube. Then, 25 µl of the mix was added into 96-well PCR plate in triplicate, the plate was covered
with an optical cover, centrifuged at 520 rpm for 30 seconds, and placed in the PCR machine.
Relative quantification was used, and the primers that correspond to the plate were chosen (GAPDH
as the endogenous control). After reading the plate, the PCR program was used for analyzing the
data. The baseline was set for CoCr, and the amplification plots were acquired. The outliers/missing
wells were omitted during the analysis.
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2.8

DATA ANALYSIS AND STATISTICS
Statistical analysis was performed using data from three independent experiments (n = 3)

and the results are presented as means ± SD. The statistical significance of differences between
surfaces was evaluated using the ANOVA with post-hoc Bonferroni’s multiple comparison tests,
Mann-Whitney test, or a 2-sample t-test with independent samples.
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3

CHAPTER THREE: COMPARING BIOCOMPATIBILITY OF
NANO-CRYSTALLINE TITANIUM AND TITANIUM-OXIDE
WITH MICRO-CRYSTALLINE TITANIUM

ABSTRACT
Ti is the material of choice for orthopaedic applications because it is biocompatible and
encourages osteoblast ingrowth. It was shown that the biocompatibility of Ti metal is due to the
presence of a thin native sub-stoichiometric Ti oxide layer which enhances the adsorption of
mediating proteins on the surface (49). The present studies were devised to evaluate the adhesion,
survival, and growth of cells on the surface of new engineered nano-crystal films of Ti and TiO2
and compare them with orthopaedic-grade Ti with micro-crystals. The engineered nano-crystal
films with hydrophilic properties are produced by employing an IBAD technique. IBAD combines
physical vapor deposition with concurrent ion beam bombardment in a high vacuum environment
to produce films (with 3 to 70 nm grain size) with superior properties. These films are “stitched”
to the artificial orthopaedic implant materials with characteristics that affect the wettability and
mechanical properties of the coatings.
To characterize the biocompatibility of these nano-engineered surfaces, we have studied
osteoblast function including cell adhesion, growth, and differentiation on different nano-structured
samples. Cell responses to surfaces were examined using SAOS-2 osteoblast-like cells. We also
studied a correlation between the surface nano-structures and the cell growth by characterizing the
SAOS-2 cells with immunofluorescence and measuring the amount alizarin red concentration
produced after 7 and 14 days. The number of adherent cells was determined by means of nuclei
quantification on the nano-crystalline Ti, TiO2, and micro-crystalline Ti and analysis were
performed with Image J. Our experimental results indicated that nano-crystalline TiO2 is superior
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to both nano- and micro-crystalline Ti in supporting growth, adhesion, and proliferation. Improving
the quality of surface oxide, i.e., fabricating stoichiometric oxides as well as nano-engineering the
surface topology, is crucial for increasing the biocompatibility of Ti implant materials.

INTRODUCTION
Osseointegration of orthopaedic implants is dependent upon different parameters of the
implant surface such as surface properties and physicochemical properties including surface
energy, charge, wettability, chemistry, and topography. Surface topography can impact cellular
behavior including adhesion, migration, morphology, and orientation in addition to focal adhesion,
the development of cytoskeleton, and differentiation (50). Surface modifications on implant
surfaces can be manipulated by etching (51), plasma deposition (52), sintering powders (53),
machining/micro-machining (54), and ion-beam assisted deposition (22).
When an implant is placed in the body, a multi-step process occurs. First, serum/plasma
proteins adsorb on the implant surface and cells attach to the protein layer by integrins which
recognize presented extracellular ligands and mediate the initial interactions of cells and the implant
material (55). After the cells adhere, there is a rearrangement of cytoskeleton proteins, formation
of tight focal adhesion contacts, activation of focal adhesion kinase, and the induction of several
intracellular signal transduction pathways, which leads to proliferation and differentiation of the
cells (55, 56). Jager et al. and Stevens et al. have shown that roughened Ti surfaces can increase
the focal contacts for cellular adhesion and they are able to guide membrane receptor organization
and cytoskeletal assembly (57, 58). In vitro experiments have shown that rough implant surfaces
promote the adsorption of FN and albumin (59, 60). In vivo osteointegration has also been improved
on roughened surfaces compared to smoother surfaces, which may suggest that the surface
modulates the response including osteoblast differentiation, ECM deposition, and calcification (61,
62). Hence, if there is an improvement in the symbiosis of the implant and osteointegration, it
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should accelerate the healing time, increase the implant longevity, and reduce the necessity of
revision surgery (55).
In the present work, osteoblast functions including cell adhesion, growth, and
differentiation on different nano-samples were investigated. Cell responses to surfaces were
examined using SAOS-2 osteoblast-like cells. We studied a correlation between the surface
topography and the cell growth by characterizing the SAOS-2 cells with immunofluorescence and
measuring the alizarin red concentration produced after 7 and 14 days.

MATERIALS AND METHODS
3.1.1

Sample Preparation
The scientific community has been actively pursuing the study of IBAD for specific

applications such as tri-biological coatings, anti-corrosion coatings, optical coatings,
superconducting buffer layers, and coatings for temperature sensitive substrates such as polymer.
IBAD (Figure 3-1) combines evaporation with concurrent ion beam bombardment in a high vacuum
environment. Energetic ions (with a depth penetration of typically less than 20 nm) were employed
to produce engineered nano-crystals “stitched” to a substrate (utilizing billions and billions of
directed and parallel ionic hammers). Ion bombardment is also the crucial factor for controlling
other film properties such as surface morphology, density, stress level, crystallinity, grain size,
grain orientation, and chemical composition (22).
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Figure 3-1: (a) IBAD system and (b) schematic. The process combines physical vapor
deposition (evaporation) with concurrent ion beam bombardment to produce a wide range of
nano-crystalline and coating (22).

The nano-crystalline TiO2 and Ti samples were prepared by IBAD technique at the Nanotechnology Laboratory of the University of Nebraska Medical Center (Figure 3-1). The IBAD
system is composed of a Veeco 12 cm RF ion gun that supplies ions at energies up to 1500 eV with
a total current density of 500 mA, which provides a broad uniform ion beam of O, N, and Ar. IBAD
experiments were carried out in an ultrahigh vacuum environment at a base pressure of 10 -8 Torr.
Using this ion beam technique, we can easily create a gradual transition between the substrate
material and the deposited film with less built-in stress than other techniques. These properties
result in films with a much more durable adhesion to the substrate, even at room temperature. Ion
bombardment also aids the production of stress-free films, eliminating stress-induced problems
such as buckling, micro-cracking, or peeling. IBAD samples were cut into 1 cm2 sections and
placed in a 50:50 mixture of acetone: methanol. Samples were sonicated for 1 hour at room
temperature, rinsed in ethanol, and dried under N2 air. Samples were wrapped in foil and autoclaved
before use.
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3.1.2

Cell Culture and Cell Seeding
A human osteoblast-like cell line (SAOS-2) was used in this research. SAOS-2 cells were

purchased from ATCC. Cells were grown in McCoy’s 5A medium (ATCC) supplemented with
15% FBS and 1% gentamycin (Invitrogen) in a humidified 5% CO2 atmosphere at 37°C. Cells were
seeded at a cell density of 10,000, 25,000, 50,000, and 75,000 cells/ml/cm2 for cell adhesion and
cell growth.
For differentiation experiments, cells were incubated in the standard McCoy’s medium
(supplemented with FBS and antibiotics) for 4 days. On day 4, 0.3 mM ascorbic acid and 10 mM
glycerol phosphate were added to the medium (differentiating medium). The medium was changed
every 3rd day and the cells were incubated for 7 and 14 days (mineralization).

3.1.3

Cell Adhesion and Fluorescence Imaging
The number of adherent cells was determined by means of nuclei quantification on the

TiO2-nano, Ti-nano, and Ti-micro substrates. Therefore, after 48 hours of incubation, SAOS-2 cells
were washed with PBS. Then the cells were fixed with 4% formaldehyde for 10 minutes and stained
with 300 nM DAPI (6-diamidino-2-phenylindole) for 5 minutes and rinsed. From each sample, 10
digital images were randomly taken with a Nikon camera using a planar 10x/0.25 objective. DAPIstained cells were automatically counted after single-channel image segmentation and binary
masking. The analysis was performed with Image J (Rasband, W.S., Image J, U. S. NIH, Bethesda,
Maryland, USA, http://imagej.nih.gov/ij/, 1997-2012).
The morphology of focal adhesions and actin of SAOS-2 cells cultured on the samples
were characterized by microscopy after immunofluorescent staining of actin (5:200, Invitrogen,
CA, USA Alexa Fluor 546 Phalloidin) and DAPI (300 nM, Invitrogen, CA, USA 6-diamidino-2phenylindole). Briefly, samples were rinsed in PBS and fixed with 4% formaldehyde for 10 minutes
at room temperature. After another rinse in 1% PBS/BSA, cells were permeabilized with 0.1%
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Triton-X 100 solution in PBS. Samples were washed with PBS 3 times for 5 minutes at room
temperature. Actin stain was added to each sample at a dilution of 5:200 for 30 minutes and rinsed
with PBS 3 times for 5 minutes at room temperature. DAPI was added to each sample (300 nM)
for 5 minutes and washed with PBS 3 times for 5 minutes at room temperature. Samples were
mounted to slides and cover-slipped until further examination.

3.1.4

Alizarin Red Staining and Quantification
Alizarin red staining was used in order to determine the calcium deposition of SAOS-2

osteosarcoma cells incubated on the nano-samples at day 7 and 14 using the Millipore Osteogenesis
Assay Kit (ECM815) according to the manufacturer. Briefly, medium was removed from the
samples and rinsed with PBS. The nano-samples were fixed in 10% formaldehyde and stained with
alizarin red stain for 20 minutes. The nano-samples were placed in 10% acetic acid for 30 minutes
to remove the monolayer, placed in a microcentrifuge tube, and heated to 85°C for 10 minutes and
centrifuged. The supernatant was neutralized with 150 μl of 10% ammonium hydroxide and the
absorbance was read at 405 nm.

3.1.5

Statistical Analysis
All data presented were derived from three independent experiments (n = 3) and within

one experiment three separate samples were analyzed. The results are presented as mean ± SD.
Statistical significant differences between three different substrates for alizarin red experiments
were evaluated using ANOVA with post-hoc Bonferroni’s multiple comparison tests.

RESULTS
Morphology of IBAD nano-crystalline Ti and TiO2 determined by atomic force microscopy
(AFM) and is shown in Figure 3-2.
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Figure 3-2: AFM images (5μm scan size) of ion beam deposited nano-crystalline
Ti and TiO2 deposited at room temperature (a) Ti with a RMS of 6.1 nm (b) TiO2
with a RMS of 1.3 nm.

3.1.6

Cell Adhesion
SAOS-2 cells were monitored for adhesion to the nano-crystalline TiO2, Ti, and medical

grade of Ti substrates at 48 hours. The number of adherent cells was determined by nuclei
quantification with DAPI in Figure 3-3. Figure 3-3a shows a higher number of cells on nanostructured surfaces compared to biomedical grade Ti, which indicates more adhesion and growth
on nano-surfaces. However, by only observing DAPI stained cells, it is impossible to know if cells
are healthy and prolific on the surface or not; besides DAPI staining, we also monitored actin fiber
shapes (Figure 3-3b and 3-3c) that show a significant difference in cell shape on nano-crystalline
TiO2 and Ti as compared to micro-crystalline Ti.

Figure 3-3: (a) Comparing the number of nuclei of SAOS-2 cells on different substrates using DAPI at 48
hours, (b) and (c) merged actin and DAPI stained cells on micro-crystalline Ti and nano-crystalline TiO2,
respectively.
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3.1.7

Cell Morphology
In order to evaluate the morphology of cells adherent to the various substrates, the attached

cells were labeled with actin and DAPI. Pronounced, large focal adhesions or thin, round shapes
with actin staining indicate larger surfaces available for adhesion and thus stronger adhesion
contacts between cell and material (63). From Figure 3-4, the overall cell morphology is flattened,
cells are well spread on the substrate, and the used timing (48 hours of incubation) allowed the cell
to go through one cell cycle, which is also an indicator of the suitability of the substrate.

(a) Nanocrystalline TiO2

(d) Nanocrystalline TiO2

(b) Nanocrystalline Ti

(c) Microcrystalline Ti

(e) Nanocrystalline Ti

(f) Microcrystalline Ti

Figure 3-4: Comparing cell adhesion on nano-crystalline TiO2, Ti, and biomedical grade of Ti by
fluorescence images microscopy. 50000 cells were incubated for 48 hours. (a), (b) and (c) are DAPI and (d),
(e) and (f) are actin stain experiments.

3.1.8

Alizarin Red Quantification
In order to determine the calcium deposition of SAOS-2 on osteosarcoma cells incubated

on different substrates on the 7th day and 14th day of the culture, alizarin red staining was
performed. Alizarin Red-S Staining (ARS) is a dye that binds selective calcium salts and is ideally
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used for calcium mineral Histochemistry (64). Results of a typical experiment performed in
quadruplicate are shown. Values are given as means ± SD.

Figure 3-5: Comparing calcium deposition on different substrates using Alizarin Red Assay
which indicates that more calcium deposited on IBAD nano-crystalline TiO2 and Ti as compared to
biomedical Ti.

CONCLUSION
Fluorescence images presented in Figure 3-4 show that cell body shape is dependent on the
surface of the substrate. If the cell appears round, it is possible that the cells recognize the surface
as “flat” and unstructured. However, the nano-roughness of the nano-substrate surfaces appears
comparable in size and structure, causing the cells to attach only slightly and to search for suitable
places for optimal anchoring (65). Figure 3-5 shows the observed matrix mineralization (Calcium)
in SAOS-2 cells. Osteoblastic cells deposit calcium in order to support bone construction. The cells
cultured on the nano-surfaces clearly show bright orange-red staining which implies a higher degree
of differentiation of the cells. Therefore, enhanced bone formation ability can be expected from the
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developed nano-structured surfaces. Our statistical analysis indicates that calcium deposition on
nano-crystalline TiO2 is significantly different from biomedical grade of Ti after 7 days. These
results indicate that the surface nano-structures affect cell interactions at the surface and alter cell
behavior when compared to conventional (microstructures) size topography. Nano-structured
surfaces possess unique properties that alter cell adhesion by direct (cell– surface interactions) and
indirect (affecting protein–surface interactions) mechanisms (65). Indeed, in recent work, we have
shown that the nano-engineered cubic ZrO2 is superior in supporting growth, adhesion, and
proliferation as compared to the micro-structured one (23). Since cell attachment is mediated by
adhesive proteins such as FN, we performed a comparative analysis of adsorption energies of FN
fragment using quantum mechanical calculations and Monte Carlo (MC) simulation, both on
smooth and nano-structured surfaces. We have found that an FN fragment adsorbs significantly
more strongly on the nano-structured surface than on the smooth surface (24).
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4

CHAPTER FOUR: EFFECTS OF NANO-ENGINEERED
SURFACES ON OSTEOBLAST ADHESION, GROWTH,
DIFFERENTIATION, AND APOPTOSIS

ABSTRACT
Modifying implant surfaces to improve their biocompatibility by enhancing osteoblast
activation, growth, differentiation, and induction of greater bone formation with stronger
attachments should result in improved outcomes for total joint replacement surgeries. This study
tested the hypothesis that nano-structured surfaces, produced by the IBAD method, enhance
osteoblast adhesion, growth, differentiation, bone formation, and maturation. The IBAD technique
was employed to deposit ZrO2 films on glass substrates. The effects of the IBAD technique on
cellular functions was investigated by comparing adhesion, proliferation, differentiation, and
apoptosis of the human osteosarcoma cell line SAOS-2 on coated vs. uncoated surfaces. IBADdeposited nano-coatings enhanced initial cell adhesion assessed by the number of DAPI-stained
cells on ZrO2 nano-coated surfaces compared to glass surfaces. This nano-modification also
increased cell proliferation as measured by mitochondrial dehydrogenase activity. Moreover, the
IBAD technique improved cell differentiation as determined by the formation of mineralized bone
nodules and by the rate of calcium deposition, both of which are in vitro indicators of the successful
bone formation. However, programmed cell death assessed by Annexin V staining and flow
cytometry was not statistically significantly different between nano-surfaces and glass surfaces.
Overall, the results indicate that nano-crystalline ZrO2 surfaces produced by the IBAD technique
are superior to uncoated surfaces in supporting bone cell adhesion, proliferation, and
differentiation. Thus, surface properties altered by the IBAD technique enhanced bone formation
and may increase the biocompatibility of bone-cell associated surfaces.
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INTRODUCTION
Degenerative joint problems due to inflammatory joint disease, obesity, aging, and other
injuries cause irreversible damage and ultimately have no solution other than total joint replacement
(TJR). More than one million patients in the United States undergo joint replacement surgery each
year, and total Medicare expenses for knee and hip replacements alone exceed three billion dollars
per year (66). The number of Americans who need TJR is expected to increase in the near future,
with a projection of over four million annually by 2030 (3). In addition to first-time TJR surgeries,
10-20% of patients need revision surgeries due to implant failures (3). Currently, orthopedic
implant lifetimes are only 10–15 years with failures due to multiple causes including infection,
inflammation, and poor osseointegration (67-69). These statistics highlight the need to develop
better technologies for TJR procedures and to produce implants that stimulate host cell adhesion
and growth. Improving osseointegration properties of bone implants decreases healing time and
increases implant longevity (69, 70). Implant surface properties, including chemical, physical, and
mechanical properties, are known to affect the responses of the cells that attach to these surfaces
(71). Surface modifications can be achieved by various techniques (72) including etching,
physicochemical coating, machining, plasma surface engineering, radiation grafting, ion beam
processing, and surface patterning. Even though these modifications have been identified, there is
still a continuing search for an optimal surface modification method to improve the
biocompatibility of implants, to enhance osteoblast activation and differentiation, and thus extend
implant longevity (69).
In 2008, Namavar et al. (22) adopted the IBAD technique to generate nano-crystalline films
with combined properties of hardness and wettability; both of which are critical determinants of
implant success and durability. Limited preliminary studies showed that these films had improved
osseointegration and other biomedical properties, due to their ultra-hydrophilic properties (22).
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Therefore, this study hypothesized that the IBAD technique would additionally improve implant
surface properties by increasing osteoblast adhesion, proliferation, differentiation, bone formation,
and maturation. To test this hypothesis, osteoblast cell adhesion, growth, differentiation, and
apoptosis of a human osteosarcoma cell line were compared between IBAD-generated ZrO2 nanocoated and uncoated glass surfaces. The results presented here suggest the likely utility of these
nano-coatings for improving orthopaedic implants.

MATERIAL AND METHODS
4.1.1

Suppliers
The ZrO2 powder for making nano-coatings was purchased from Alfa Aesar (#36319,

Tewksbury, MA) and glass substrates were Fisherfinest premium plain glass microscope slides
(#125441, Waltham, MA). The human osteosarcoma cell line SAOS-2 was obtained from the
ATCC (#HTB-85, ATCC, Manassas, VA), and cultured in McCoy’s 5A medium (#30-2007,
ATCC, Manassas, VA). The medium was supplemented with FBS (#S11550, Atlanta Biologicals,
Flowery Branch, GA) and gentamycin (#15750060, Life Technologies, Grand Island, NY). For
mounting samples to the slides and coverslips, Fluormount-G (#0100-01, SouthernBiotech,
Birmingham, AL) was used. Metabolic activity was measured using CellTiter 96 AQueous One
solution cell proliferation assay from Promega (#G3582, Madison, WI). An Alexa Fluor 488
Annexin V/Dead cell apoptosis kit was purchased to measure the programmed cell death with
Alexa Fluor 488 Annexin V and PI for flow cytometry from Invitrogen (#V13241, Eugene, OR).
The osteogenesis assay kit was obtained from Millipore (#ECM81, Billerica, MI) and employed
according to the manufacturer’s instructions.

4.1.2

Nano-fabrication
Nano-surfaces were prepared using the IBAD technique precisely as described by Namavar

et al. (22). This technique utilizes a combination of an electron beam evaporation system with
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concurrent ion beam bombardment in a very high vacuum environment (10-8 Torr). These energetic
ions attach a nano-crystalline thin film of ZrO2 to the substrate. Ion bombardment is the critical
factor for controlling film properties including morphology, density, stress level, crystallinity, grain
size, grain orientation, and chemical composition (22). Using the IBAD technique to modify
surface properties was previously shown to result in stress-free films with more durable adhesion
to a Ti substrate (73). Glass substrates were tested here to eliminate inherent surface properties of
metal surfaces, allowing the focus solely on the specific nano-coating properties.

4.1.3

Sample Preparation
Both nano-coated and uncoated glass surfaces were cut into 1 cm x 1 cm samples, sonicated

for 2 hours in 50:50 acetone:methanol mixture, and rinsed in ethanol. The samples were wrapped
in aluminum foil and autoclaved to ensure sterile surfaces for cell culture studies.

4.1.4

Cell Culture
Cell culture studies were performed using the human osteosarcoma cell line SAOS-2,

which was derived from the primary osteosarcoma of an 11-year-old Caucasian girl (74). Cells
were grown in McCoy’s 5A medium supplemented with 15% heat-inactivated FBS and 1%
gentamycin in a humidified 5% CO2 atmosphere at 37°C.
For differentiation experiments, cells were grown in McCoy’s medium supplemented with
FBS and gentamycin for 4 days. From day 4, cell cultures were maintained in the same medium
supplemented with 0.3 mM ascorbic acid and 10 mM glycerol phosphate (differentiation medium).
The cells were incubated for 7, 14, or 21 days, with fresh medium changes every 3 days.

4.1.5

Survival
To compare programmed cell death of SAOS-2 cells on uncoated and ZrO2 nano-coated

glass surfaces, an Annexin V kit with PI staining was used. Preparation of 1X Annexin-binding
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buffer and 100 µg/mL working solution of PI was prepared based on the manufacturer's protocol.
Three samples of each substrate were placed in 12-well plates, and 500,000/ml cell with 2 ml of
suspension medium was seeded on the top of each sample (1 million cells per well) and incubated
for 24 hours in a CO2 incubator at 37°C. After 24 hours, all samples were transferred to a fresh 12well plate, fresh medium was added, and incubated for 3 more days. At day 4 after plating, the
medium was removed, samples were washed with 1 ml PBS, and 500 µl of Accutase was added to
each well. The samples were incubated for 10 minutes at room temperature, 2 ml of medium was
added to each well, and detached cells were transferred to separate 15-ml conical tubes, and
centrifuged. The cells were washed with cold PBS, re-centrifuged, and re-suspended in 1X
Annexin-binding buffer. To each 100 µL of cell suspension, 5 µL Alexa Fluor 488 Annexin V and
1 µL 100 µg/mL PI working solution. Following incubation at room temperature for 15 minutes in
the dark, 400 µL of 1X Annexin-binding buffer was added to each tube and mixed gently. Samples
were placed on ice and analyzed within 1 hour by flow cytometry measuring the fluorescence
emission at 530 nm and 575 nm or equivalent using 488 nm excitation. A total, 10,000 events were
collected for each sample. The population was separated into three groups: live cells showed only
a low level of fluorescence, apoptotic cells showed green fluorescence, and dead cells showed both
red and green fluorescence. Data are expressed as the average percent viability.
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Figure 4-1: Comparison of viability (early apoptosis, late apoptosis, and necrosis) of
coated and uncoated surfaces. The percentage of viable SAOS-2 cells was quantified by
measuring fluorescence using flow cytometry (n = 3, means ± SD).

4.1.6

Adhesion
For quantifying adherent cells, different densities of SAOS-2 cells were cultured as

described above in 12-well plates. After 24 hours, samples were washed with 1x PBS containing
1% BSA, fixed with 1 ml of 4% formaldehyde for 10 minutes, and permeabilized with 1 ml of 0.1%
Triton-X-100 for 5 minutes, all at room temperature. Samples were stained with DAPI (1 ml of a
300 nM stock solution of 4', 6- diamidino-2-phenylindole dihydrochloride in PBS per sample) for
5 minutes in the dark at room temperature. Between all steps above, cells were washed twice with
PBS/1% BSA buffer. Samples were fixed to the slides and coverslips were attached with
Fluormount-G. Cells were quantified using ImageJ software (IJ 1.45 m, National Institutes of
Health, Bethesda, MD), and data are expressed as the average number of DAPI-stained cells in 15
random fields captured at 10x.
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Figure 4-2: Comparison of initial cell adhesion on coated and uncoated surfaces

Different cell numbers were seeded on nano-ZrO2 and glass surfaces. The number of
adherent SAOS-2 cells 24 hours after seeding was quantified by counting DAPI-stained cells from
15 random images captured at 10x (n = 3, means ± SD).
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Table 4-1: Number of adherent SAOS-2 cells on coated and uncoated
surfaces 24 hours after seeding
Cell attachment
mean +/- SD

Cell seeding

4.1.7


Ratio

P-value

Glass

ZrO2

10,000

14 ± 03

55 ± 18

3.9

.0001

25,000

52 ± 09

63 ± 09

1.2

.0020

50,000

79 ± 09

132 ± 17

1.7

.0001

75,000

130 ± 10

186 ± 30

1.4

.0001

100,000

190 ± 18

314 ± 22

1.7

.0001

Proliferation
Metabolic Activity
As an indicator of cell viability and proliferation, the metabolic activity of SAOS-2 cells

on coated and uncoated surfaces was determined using an MTS assay. Culturing 500,000/ml cell
with 2 ml of suspension added to samples was performed as previously. After 24 hours, all samples
were transferred to a fresh 12-well plate, fresh medium was added, and incubated for 3 more days.
At day 4 after plating, the medium was removed from the samples, 200 µl of fresh medium, and 40
µl MTS dye solution was added to each sample. The plates were incubated in a CO2 incubator at
37°C for 3 h. After this incubation period, 100 µl of supernatant was transferred into each well of
a 96-well plate and absorbance of the MTS formazan dye product was measured photometrically
at 490 nm with an Infinite M200 (Tecan, Morrisville, NC) plate reader. The cells in each well were
stained with DAPI and visualized at 10x by fluorescence microscopy as described in the cell
counting section.
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Figure 4-3: Comparison proliferating cells absorbance on coated and
uncoated surfaces based on MTS assay.

SAOS-2 cells were plated on either uncoated or ZrO2 nano-coated glass surfaces (1 million
cells per sample), and proliferation was assessed after 4 days using MTS assays (n = 3,
means ± SD). The statistical differences were evaluated using independent samples t-test.

ZrO2

Glass

Figure 4-4: Visualization of SAOS-2 cells at day 4 to assess adhesion and proliferation on coated and
uncoated surfaces.
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SAOS-2 cells were plated on ZrO2 nano-coated and uncoated glass substrates (1 million
cells per sample), and allowed 24 hours to adhere, followed by 3 additional days of proliferation.
After 4 days, cells were stained with DAPI (blue). Results are from one experiment representative
of those from 3 independent experiments with random images taken at 10x magnification. The
statistical differences were evaluated using the independent sample T-test.

4.1.8


Differentiation
Alizarin Red Assay
To determine calcium deposition, SAOS-2 cells were cultured as described previously,

incubated on the different surfaces for 7 days in 24-well plates, and alizarin red staining was
performed as follows. After removing medium from the samples and rinsing with PBS, samples
were transferred to fresh plates and fixed with 10% formaldehyde at room temperature for 15
minutes. Samples were rinsed 3 times with de-ionized water, 1 ml alizarin red stain solution was
added to each well, followed by incubation at room temperature for 20 minutes. Excess dye was
removed by 4 washes with de-ionized water, 400 µl of 10% acetic acid was added to each well, the
plates were incubated for 30 minutes with shaking, and the mixtures were transferred to 1.5-ml
centrifuge tubes. To remove the cell monolayer, samples were vortexed for 30 seconds and then
incubated at 85°C for 10 minutes in a block heater. Tubes were placed on ice for 5 minutes and
then centrifuged at 20,000 g for 15 minutes. A 400-µl portion of the supernatant was transferred to
a fresh 1.5-ml centrifuge tube, and the pH was neutralized with 150 μl of 10% ammonium
hydroxide (pH 4.1-4.5). Finally, 150 µl of the mixture in each tube was transferred to one well of
a 96-well plate, and the absorbance at 405 nm was quantified.
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4.1.9

Statistical Analysis
Statistical analysis was performed using data from three independent experiments (n = 3),

and the results are presented as means ± SD. The statistical significance of differences between
surfaces was evaluated using the Mann-Whitney test or the 2-sample t-test with independent
samples.

RESULTS
The program cell death of SAOS-2 cells assessed by Annexin V kit with PI staining (Figure
4-1) showed no differences between uncoated and ZrO2 nano-coated glass surfaces in early
apoptosis (p = .842), late apoptosis (p = .074), and necrosis (p = .853) suggesting that differential
toxicities of the surfaces was not a factor in outcomes.
Adherence of SAOS-2 cells to coated and uncoated surfaces 24 hours after culturing on the
top of surfaces at different densities assessed by counting DAPI-stained cells was 1.3- to 3.9-fold
greater on ZrO2 nano-coated compared to uncoated glass surfaces (Figure 4-2 and Table 4-1),
indicating greater adhesion on nano-surfaces.
The proliferation of SAOS-2 cells assessed by metabolic activity in MTS assays was 1.6fold higher for cells on ZrO2 nano-coated vs. uncoated glass surfaces at day 4 after culturing (Figure
4-3), indicating higher metabolic activities of those cells.
Similarly, the proliferation of cells visualized by DAPI staining at day 4 after plating
appeared to show greater adhesion and proliferation for cells plated on ZrO 2 nano-coated than vs.
uncoated glass surfaces (Figure 4-4). These data indicated not only greater proliferation on nanosurfaces but also a more uniform distribution of the cells on those surfaces.
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Calcium deposition, assessed by alizarin red staining, was 1.2-fold higher for cells on ZrO2
nano-coated vs. uncoated glass surfaces on day 7 of culture, indicating higher calcium deposition
in differentiation, by cells grown on these nano-surfaces.

DISCUSSION
Early and late apoptosis and also necrosis of SAOS-2 cells on uncoated and ZrO2 nanocoated glass surfaces showed no difference. The viability percentage for these data is a combination
of the survival of the cells on the substrates, and their death because of apoptosis/necrosis as a
response to surfaces or a combination of both. The Annexin V kit with PI staining cannot
differentiate between these assumptions and but was used as a starting point for further
investigation.
Both adhesion and proliferation of SAOS-2 cells assessed by counting DAPI-stained cells
were greater on ZrO2 nano-coated compared with uncoated glass surfaces, indicating that nanocoating enhance cell interactions with the surface and altered cell behavior. Moreover, cell
distributions on the coated and uncoated surfaces were different. Cells showed a more uniform
distribution on ZrO2 nano-coated compared with uncoated glass surfaces, where the cells adhered
in the form of clumps. This difference indicates that adhesion of these cells is more compatible
with nano-coated surface compared to the uncoated ones and it appears on the glass surfaces; they
prefer to stick to each other (potentially to maintain viability) than adhere to the surface.
The metabolic activity in MTS assays was 1.3-fold higher for cells on ZrO2 nano-coated
vs. uncoated glass surfaces at day 4 after plating, and independent samples t-test showed a P value
= .033. This result indicates that cells seeded on nano-coated surfaces showed increased metabolic
activity and growth rates when compared with the uncoated glass surface as a control.
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These data show that cells not only attached and proliferated more on the ZrO2 nano-coated
surface compared with the uncoated surface, but that they also appeared healthier. Taken together,
these data suggest that ZrO2 nano-coatings can accelerate and increase adhesion, proliferation, and
subsequent metabolic activity of osteoblasts compared with uncoated surfaces. Increasing the
extent of host cell adhesion and the rate of growth could likely lead to accelerated integration and
decreased healing time for patients and increased longevity for implants.
Calcium deposition, assessed by alizarin red staining, is an indicator of late differentiation
and bone formation capability of the osteoblast-like cells that are responsible for bone formation
(75). Calcium deposition measured on day 7 of culture was 1.2-fold higher for cells on ZrO2 nanocoated vs. uncoated glass surfaces. Osteoblastic cells deposit calcium to support bone formation.
Therefore, in a clinical setting, the enhanced bone formation would be expected from cells grown
on nano-crystalline ZrO2 compared to uncoated glass surfaces.
Although this study tested nano-coatings on glass substrates, our previous study using Ti
substrates showed similar results (73). The main reason for choosing glass substrates for the current
study was to avoid the effect of any surface roughness other than the nano-roughness produced by
the IBAD technique. The natural micro-roughness of Ti and its oxides improve its biocompatibility,
and this is a major reason that Ti-based materials are an optimal choice for implants (49). Using
smooth glass substrates instead of any other material with inherent micro-scale roughness and
porosity made it possible for us to isolate the specific effects of the nano-roughness produced by
the IBAD technique from other factors that might influence cell interactions with surfaces. Glass
surfaces are also neutral, another advantageous property for in vitro experiments.
The results here document that nano-crystalline ZrO2 surfaces improve the adhesion,
proliferation, and differentiation of SAOS-2 bone-forming cells in vitro compared with the same
cells on uncoated glass surfaces. These findings indicate the importance of the unique properties of
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IBAD-produced nano-films for surface biocompatibility. There are additional unique properties of
these surfaces that make them ideal for osseointegration applications and beneficial for increasing
the biocompatibility of implant materials; the most important are grain size, wettability, and
hardness (22). An ideal biomaterial should have several fundamental properties simultaneously,
including biocompatibility, high strength, bone-bonding ability, and resistance to fatigue,
corrosion, and wear (69). However, no known materials possess these combined properties. For
example, ceramics have high biocompatibility and enhanced corrosion resistance, but they are
brittle and can fracture because of their low plasticity. Moreover, as they become oxidized, they
release ions into the body that can lead to immune system reactions and implant degradation (76).
Aluminum and Zr are suitable for load-bearing applications because they possess high wear
resistance, but there are cases of mechanical failures with these materials (76). Because interactions
with foreign bodies are very complicated, more studies are needed to understand the in vivo
behavior of implant materials better. Hence, research continues to develop new coating
technologies and to make advanced implant materials that reduce failure by addressing these many
challenges, simultaneously. The promising in vitro results presented here provide support for
further testing of IBAD-generated surface modifications in animal models for potential future use
as significantly improved materials for human implants.
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5

CHAPTER FIVE: SURFACE NANO-MODIFICATION BY ION
BEAM ASSISTED DEPOSITION ALTERS THE EXPRESSION OF
OSTEOGENIC GENES IN OSTEOBLASTS

ABSTRACT
Biomaterials with enhanced biocompatibility are favored in implant studies to improve the
outcomes of total joint replacement surgeries. This study tested the hypothesis that nano-structured
surfaces, produced by the IBAD method, would enhance osteointegration by altering the expression
of bone-associated genes in osteoblasts. The IBAD technique was employed to deposit nano-films
on glass or Ti substrates. The effects of the IBAD technique on the human osteosarcoma cell line
SAOS-2 at the molecular level was investigated by assays of adhesion, proliferation,
differentiation, and apoptosis on coated surfaces vs. uncoated CoCr as the control. IBAD nanocoatings enhanced bone-associated gene expression at initial cell adhesion, proliferation, and
differentiation compared to CoCr surfaces as assessed by PCR techniques. Increased cell
proliferation was observed using a nuclear cell proliferation-associated antigen. Moreover,
enhanced cell differentiation was determined by ALP activity, an indicator of bone formation. In
addition, programmed cell death assessed by annexin V staining and flow cytometry was lower on
nano-surfaces compared to CoCr surfaces. Overall, the results indicate that nano-coated surfaces
produced by the IBAD technique are superior to orthopaedic grade CoCr in supporting bone-cell
adhesion, proliferation, differentiation, and reducing apoptosis. Thus, surface properties altered by
the IBAD technique should enhance bone formation and increased the biocompatibility of bonecell associated surfaces.
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INTRODUCTION
Total joint replacement (TJR) is among the top ten most costly and rapidly increasing
procedures in the United States due to the aging population, bone fractures, and increasing obesity
(77). In addition, biomaterial studies also have shown a rapid growth rate in the face of the
challenge of finding biomaterials with the optimal physical, mechanical, and wear properties
necessary for orthopaedic purposes (78, 79). The biomaterials used in implants are usually metals,
polymers, ceramics, and composites (79). There are several metallic biomaterials with sufficient
hardness, strength, corrosion resistance, and biocompatibility, including stainless steel, Ti alloys,
and CoCr alloys, that make them a good option for TJR (78). Stainless steel was the first material
used in this category regarding its easy casting and proper mechanical properties. However, some
alloying elements including nickel and molybdenum are problematic, mainly due to corrosion (79).
Ti and Ti-based alloys are light, biocompatible, and have good mechanical and chemical properties.
However, they have the weak shear strength that limits their applications (79). CoCr alloys are
highly resistant to corrosion and therefore considered the safest biomaterials for orthopedic
prostheses (79, 80). The biocompatibility of the implants can also be modified using a variety of
surface modification techniques (69). Understanding the impact of these modifications and also the
role of surface chemistry and topography on the osseointegration require many standardized in vitro
and in vivo tests (59).
This study evaluated, at the molecular level, the approach of Namavar et al. (22) that
introduced the IBAD technique to coat nano-crystalline films with combined controllable
properties of hardness and wettability on different substrates. Our previous study showed that
IBAD-produced nano-crystalline ZrO2 surfaces improved the adhesion, proliferation, and
differentiation of SAOS-2 bone-forming cells in vitro compared with the same cells growing on
uncoated glass surfaces.
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This study evaluated these differences at the molecular level by investigating gene
expression modifications and protein generation. Therefore, we hypothesized that the IBAD
technique would improve implant surface properties by optimizing the expression of boneassociated genes. To test this hypothesis, bone-associated gene expression of a human
osteosarcoma cell line were compared between IBAD-generated nano-surfaces and uncoated CoCr
surfaces in the processes of adhesion, proliferation, and differentiation. In addition, protein
generation was studied using ELISA and flow cytometric assays. The results presented here suggest
the likely utility of these nano-coatings for improving the integration of orthopaedic implants.

MATERIAL AND METHODS
5.1.1

Suppliers
The ZrO2 and TiO2 powder used as source materials for nano-coatings were purchased from

Alfa Aesar (#36319 and #36199, Tewksbury, MA), Ti and CoCr substrates were orthopaedic grades
purchased from Edge International (CoCrMo ASTM F1537, Dayton, Ohio), and glass substrates
used for coating were Fisherfinest premium plain glass microscope slides (#125441, Waltham,
MA). The SAOS-2 cell line that is a human osteosarcoma was purchased from the ATCC (#HTB85, ATCC, Manassas, VA), cultured in McCoy’s 5A medium (#30-2007, ATCC, Manassas, VA) ,
and supplemented with FBS (#30-2020, ATCC, Manassas, VA) and gentamycin (#15750060, Life
Technologies, Grand Island, NY). Proliferation was measured using PE Mouse Anti-Human Ki-67
Set (RUO) from Biosciences (#556027, San Jose, CA). The alexa fluor 488 annexin V/Dead cell
apoptosis (programmed cell death) kit including alexa fluor 488 annexin V and PI (propidium
iodide) for flow cytometry was purchased from Invitrogen (#V13241, Eugene, OR). The SensoLyte
pNPP ALP assay kit was obtained from Anaspec (#AS-72146, Fremont, CA) and employed
according to the manufacturer’s instructions. To normalize data from ALP assay, the BCA protein
assay was employed. The Quant-iT PicoGreen dsDNA assay kit was obtained from Invitrogen
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(#P11496, Eugene, OR) and Pierce BCA protein assay kit from Thermo Scientific (#23227,
Rockford, IL).

5.1.2

Nano-fabrication
All nano-surfaces including ZrO2 on Glass, ZrO2 on Ti and TiO2 on Ti were coated using

IBAD technique as described by Namavar et al. (22). A combination of an electron beam
evaporation system with a simultaneous ion beam bombardment in a high vacuum environment
(10-8 Torr), stitches a nano-film of the source material to the desired substrate material. The unique
characteristics of this nano-film affect mechanical properties and the wettability by controlling the
crystallinity, chemical composition, grain size, density, and grain orientation (22).

Figure 5-1: Schematic of the IBAD system
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5.1.3

Sample Preparation
Nano-coated surfaces were cut into 10 mm by 10 mm squares (area = 100 mm2), and CoCr

samples were cut into disks with 12.7 mm diameter (area = 127 mm2), polished, sonicated for 1
hour in 50:50 acetone:methanol mixture, wrapped in aluminum foil and autoclaved.

5.1.4

Cell Culture
The cell line used for this study was SAOS-2, a primary human osteosarcoma obtained

from the ATCC and originally derived from an 11-year-old Caucasian girl (74). Based on the
ATCC protocol, cells were cultured in McCoy’s 5A medium, supplemented with 15% heatinactivated FBS and 1% gentamycin in a humidified 5% CO2 atmosphere at 37°C.
The differentiation medium, used for ALP and PCR experiments, employed the same
medium as above, supplemented with 0.3 mM ascorbic acid and 10 mM glycerol phosphate.

5.1.5

Cellular Responses to Surfaces

5.1.5.1 Proliferation
For comparing osteosarcoma cell proliferation on different surfaces, the Ki-67 assay was
used. Ki-67, a nuclear cell proliferation-associated antigen expressed by all proliferating human
cells, can be recognized at all stages of the cell cycle (late G1, S, M, and G2 phases) except for
G0 phase (39). About 30 flasks of cells were harvested at 50% confluency using trypsin, detached
cells were adjusted to 500,000 cells per 2 ml (250,000/ml), 3 samples of each surface were placed
in a 12-well plate, and each sample was seeded with 500,000 cells (2 ml for each well), and
incubated for 24 hours. After 24 hours, samples were transferred to a fresh 12-well plate, fresh
medium was added and incubated for 3 more days. At day 4 after plating, samples were washed
with 1 ml PBS once, 500 µl of accutase were added to each well, and incubated for 10 minutes at
room temperature. After 10 minutes, 2 ml of medium was added to the each well, detached cells
were collected in separate 15-ml conical tubes, centrifuged at 200 g for 5 minutes, the supernatant
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was discarded, 5 ml of cold 70% - 80% ethanol was added drop by drop into the cells pellet in each
tube, mixed well and were incubated at -20°C for 24 hours. For Ki-67 staining by flow cytometry,10
ml wash buffer (PBS with 1% FBS, 0.09% NaN3 pH7.2) was added to the fixed cells in each tube,
centrifuged for 5 minutes at 200 g and supernatant was aspirated. One more wash was performed
as described; cells were resuspended in 100 µl wash buffer, 20 μl of antibody was added into the
tubes and mixed gently. Tubes were incubated at room temperature for 30 minutes in the dark,
washed with 2 ml of PBS washing buffer, centrifuged at 200 g for 5 minutes, and 0.5 ml of PBS
wash buffer was added into each tube. The samples were analyzed by FACS.

Ki-67 expression of SAOS-2 cells on different surfaces
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Figure 5-2: Comparison of proliferating cells on coated nano-surfaces and uncoated CoCr
based on Ki-67 expression.

SAOS-2 cells were plated on either uncoated or nano-coated surfaces (1 million cells per
sample), and proliferation was assessed after 4 days using ki-67 assays (n = 3, means ± SD). The
statistical differences were evaluated using independent samples t-test.
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5.1.5.2 Apoptosis
To compare programmed cell death of SAOS-2 cells on different surfaces, an annexin V
kit with PI staining was used. In the early stages of apoptosis, PS is translocated from the inner to
the outer layer of the cytoplasmic membrane. This translocation marks it for recognition and
phagocytosis by macrophages (42). Annexin V is a protein with high affinity for PS that is labeled
with a fluorophore. This kit also includes red fluorescent propidium iodide (PI) nucleic acid binding
dye that is impermeable to live cells and apoptotic cells, but stains dead cells with red fluorescence.
Therefore, apoptotic cells show green fluorescence, dead cells show red and green fluorescence,
and live cells show little or no fluorescence. These populations can be distinguished using a flow
cytometer with a 488 nm excitation laser. About 30 flasks of cells were harvested at 50%
confluency using trypsin, and the detached cells were adjusted to 1,000,000 cells per 2 ml
(500,000/ml), 3 samples of each surface were placed in a 12-well plate and each sample was seeded
with 1,000,000 cells (2 ml for each well), and incubated for 24 hours. After 24 hours, samples were
transferred to a fresh 12-well plate; fresh medium was added and incubated for 3 more days. At
day 4 after plating, 1X annexin-binding buffer, and PI working solution were prepared based on
the manufacturer's protocol. Subsequently, samples were washed with 1 ml PBS, 500 µl of accutase
was added to each well, and incubated for 10 minutes at room temperature. After 10 minutes, 2 ml
of medium was added to each well; detached cells were collected in separate 15-ml conical tubes,
centrifuged at 200 g for 5 minutes, supernatant was discarded, cells were washed with cold PBS,
and resuspended in 1X annexin-binding buffer, and 5 µL alexa fluor 488 annexin V and 1 µL 100
µg/mL PI working solution were added to each 100 µL of cell suspension and incubated at room
temperature for 15 minutes in the dark. After the incubation period, 400 µL 1X annexin-binding
buffer was added to the samples, mixed gently, and kept on ice for analysis within 1 hour by flow
cytometry, measuring the fluorescence emission at 530 nm and 575 nm or equivalent, using 488
nm excitation. From each sample, 10,000 events were collected, and the population was separated
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into three groups: live cells (little or no fluorescence), apoptotic cells (green fluorescence), and
dead cells (red and green fluorescence). Data are expressed as the average percent viability.
Controls that were used included unstained cells, cells stained with annexin V conjugate only (no
PI), and cells stained with PI only (no annexin V conjugate).
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Figure 5-3: Comparison of viability (late apoptosis) of nano-coated and uncoated CoCr
surfaces.

The percentage of viable SAOS-2 cells was quantified by measuring fluorescence using
flow cytometry (n = 3, means ± SD).
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Figure 5-4: Comparison of viability (early apoptosis) of nano-coated and uncoated CoCr
surfaces.

The percentage of viable SAOS-2 cells was quantified by measuring fluorescence using
flow cytometry (n = 3, means ± SD).
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Figure 5-5: Comparison of viability (necrosis) of nano-coated and uncoated CoCr surfaces.
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The percentage of viable SAOS-2 cells was quantified by measuring fluorescence using
flow cytometry (n = 3, means ± SD).

5.1.5.3 Differentiation
In order to compare osteosarcoma cell differentiation on the different surfaces, an ALP
assay was used. A bone-specific isoform of ALP is found on the cell surface of osteoblasts that are
responsible for the synthesis of the new bone matrix and its mineralization. The SensoLytepNPP
ALP assay kit can detect ALP by ELISA using colorimetric pNPP phosphatase substrate at
absorbance 405 nm. About 30 flasks of cells were harvested at 50% confluency using trypsin, and
detached cells were brought to the 500,000 cells per 2 ml (250,000/ml) density, 3 samples of each
surface were placed in a 12-well plate, and each sample was seeded with 500,000 cells (2 ml for
each well), and incubated for 24 hours. After 24 hours, samples were transferred to a fresh 12-well
plate. Fresh medium was added and incubated for another day. At day 2 after plating, differentiating
medium was added and incubated for 3 more days. At day 5 after plating, 1X assay buffer, pNPP
ALP substrate working solution, and Triton X buffer were prepared according to the manufacturer's
instructions. To prepare cell extracts, 500 µl of the Triton X buffer was added to each sample, cell
suspensions were incubated the at 4°C for 10 minutes under agitation (100 rpm), collected in a
microcentrifuge tube, centrifuged at 2500 g for 10 minutes at 4°C, and the supernatant was collected
for ALP assay. To detect ALP activity, 100 µL of pNPP substrate working solution was added into
each well, mixed by gently shaking the plate for 30 seconds, and incubated at room temperature for
60 minutes in the dark. After the incubation period, 50 µL of stop solution was added into each
well, and the absorbance was measured at 405 nm using Epoch (Biotek, Winooski, VT) microplate
spectrophotometer. ALP activity of cell lysates was extrapolated from the ALP standard curve, and
the ALP activity was normalized according to the number of cells in the cell lysates using BCA
protein assay. This assay is based on BCA for the colorimetric detection and quantitation of total
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protein. One cuprous ion forms a complex with two BCA molecules, producing a purple-colored
water-soluble complex that absorbs light at 562 nm. The absorbance data were plotted against the
standard curve to calculate the concentration of protein in samples.

ALP Activity of SAOS-2 cells on different surfaces
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Figure 5-6: Comparison of differentiation on coated and uncoated surfaces based on ALP
activity.

SAOS-2 cells were seeded on nano-coated and CoCr surfaces (1 million cells per sample),
and differentiation was assessed after 5 days using ALP assay (n = 3, means ± SD). The statistical
differences were evaluated using independent samples t-test.

5.1.6

Gene Expression Modified by the Cell to Surface Interactions
In order to determine the responses of human osteoblast cells to implant surfaces, the gene

expression profiles as modified by the cell to surface interactions such as initial adhesion,
proliferation, and differentiation were measured using PCR techniques. RNA from cells cultured
on the various surfaces was extracted and evaluated by real-time PCR for the osteogenic markers
and matrix proteins listed in Table 5-1.
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Table 5-1: List of genes used for PCR experiments
Target Gene

Abbreviation

Implication

RUNX 2

RUNX 2

Early osteoblastic transcription factor

Osterix

SP7

Transcription factor in osteoblast differentiation

Alkaline phosphatase

ALPL

Marker for bone mineralization (initial stage)

Osteopontin

SPP1

Marker for middle stage osteogenic differentiation

Fibronectin

EGFLAM

Promoting cell attachment and migration

Ki-67

MKI67

Proliferation marker

Bone morphogenetic protein 2

BMP2

Stimulates the production of bone

GAPDH

GAPDH

Control (housekeeping gene)

About 130 flasks of cells were harvested at 50% confluency using trypsin, and detached
cells were adjusted to 500,000 cells per 2 ml (250,000/ml) density. For each adhesion, proliferation
and differentiation set, 3 samples of each surface were placed in separate 12-well plates. Each
sample was seeded with 500,000 cells (2 ml for each well) and incubated for 24 hours. After 24
hours, adhesion set samples were harvested, but the samples from proliferation and differentiation
samples were transferred to fresh 12-well plates, and fresh medium was added. The proliferation
samples were incubated for 3 more days and harvested on day 4. For differentiation samples, at day
2 after plating, differentiation medium was added, samples were incubated for 3 more days, and
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were harvested at day 5 after plating. Cells were harvested using accutase as previously described.
Detached cells were placed in separate centrifuge tubes, centrifuged at 14,000 rpm for 5 minutes,
and the supernatant was discarded. To isolate RNA, QIAGEN RNeasy mini kits were used. Cells
were resuspended in 350μL RLT buffer, vortexed for 5 seconds, pipetted onto a QIAshredder spin
column, centrifuged at 14,000 rpm for 2 minutes and the lysate was transferred to a gDNA
eliminator spin column, centrifuged at 10,000 rpm for 30 seconds, and the flowthrough was saved.
Then, 350μL of 70% ethanol was added to the lysate, mixed well by pipetting, 700μL of the sample
was applied to an RNeasy mini column, centrifuged at 10,000 rpm for 20 seconds and the
flowthrough was discarded. Next, 700μL Buffer RW1 was added to the column, centrifuged at
10,000 for 20 seconds, the flowthrough was discarded, and columns were transferred to new 2-mL
collection tubes. Subsequently, 500μL Buffer RPE was pipetted onto the column, centrifuge at
10,000 for 20 seconds, flowthrough was discarded, 500μL buffer RPE was added to the column,
centrifuged at 10,000 rpm for 2 minutes. Columns were transferred to a new 1.5-mL collection
tube, 50μL RNase-free water was pipetted onto the column membrane and centrifuged at 10,000
rpm for 1 minute. RNA quantification was performed at this stage to ensure successful isolation.
For reverse transcription, cDNA master mix was made by adding 6 µl of 10x RT Buffer, 6 µl of
10x Random Primer, 3 µl of Multiscribe, 2.4 µl of 25x dNTPs, and 12.6 µl of nuclease-free water
per reaction. Then, 30 µl of RT master mix and 30 µl of each RNA sample were added in separate
centrifuge tubes, incubated at room temperature for 10 minutes in an incubator at 37°C for 2 hours,
and then in a heat block at 85°C for 5 minutes, and stored at 4°C in the dark. To achieve the desired
volume for each PCR, 70 µl of nuclease-free water was added to each cDNA sample. The PCR
master mix for each sample and each primer was generated by adding 50 µl of TaqMan Master
Mix, 5 µl of specific primer, 10 µl of cDNA Sample, and 35 µl of Nuclease-free water to a small
tube. Then, 25 µl of the mix was added into 96-well PCR plate in triplicate, and the plate was
covered with an optical cover, centrifuged at 520 rpm for 30 seconds, placed in the PCR machine
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(Biosystems 7500 Real-time PCR System). Relative quantification was used, and the primers that
correspond to the plate were chosen (GAPDH as the endogenous control). After reading the plate,
PCR program was used for analyzing the data. The baseline was set for CoCr, and the amplification
plots were acquired. The outliers/missing wells were omitted during the analysis.
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Figure 5-7: Comparison of average gene expression in the adhesion experiments

Comparison of average gene expression in the adhesion experiments on coated nanosurfaces and uncoated CoCr, using PCR technique. SAOS-2 cells were plated on either uncoated
or nano-coated surfaces (1 million cells per sample), and RNA was harvested after 24 hours (n =
3, means ± SD). The statistical differences were evaluated using independent samples t-test.
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Figure 5-8: Comparison of average gene expression in the proliferation experiments

Comparison of average gene expression in the proliferation experiments on coated nanosurfaces and uncoated CoCr, using PCR technique. SAOS-2 cells were plated on either uncoated
or nano-coated surfaces (1 million cells per sample), and RNA was harvested after 4 days (n = 3,
means ± SD). The statistical differences were evaluated using independent samples t-test.
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Figure 5-9: Comparison of average gene expression in the differentiation experiments

Comparison of average gene expression in the differentiation experiments on coated nanosurfaces and uncoated CoCr, using PCR technique. SAOS-2 cells were plated on either uncoated
or nano-coated surfaces (1 million cells per sample), and RNA was harvested after 5 days (n = 3,
means ± SD). The statistical differences were evaluated using independent samples t-test.

5.1.7

Data Analysis and Statistics
Statistical analysis was performed using data from three independent experiments (n = 3),

and the results are presented as means ± SD. The statistical significance of differences between
surfaces was evaluated using the 2-sample t-test with independent samples.

RESULTS
The proliferation of SAOS-2 cells assessed by nuclear cell proliferation-associated antigen
Ki-67 was higher for cells on nano-coated surfaces vs. uncoated CoCr surfaces at day 4 after
culturing (Figure 5-2). Median Ki-67 expression for ZrO2 on the glass, ZrO2 on Ti, and TiO2 on Ti
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were 1.3, 1.7, and 1.2 fold higher than CoCr relatively, indicating higher proliferation of SAOS-2
cells on those surfaces. Also, statistical analysis showed a significant difference in Ki-67 expression
of the cells between nano-ZrO2 on Ti vs. CoCr (p = .038).
Programmed cell death of SAOS-2 cells assessed using an annexin V kit with PI staining
(Figure 5-3, 5-4, 5-5) showed significant differences between uncoated CoCr and ZrO2 nano-coated
glass surfaces in both early apoptosis (p = .029) and late apoptosis (p = .007), suggesting that
differential toxicity of the surfaces and cellular stress induced by those surfaces were factors in
outcomes. No significant differences between uncoated CoCr and ZrO2 nano-coated glass surfaces
were observed for necrosis (p = .094).
Osteoblastic differentiation measured by ALP activity was 2.8, 1.5, and 1.4 -fold higher
for cells on nano-coated ZrO2 on the glass, ZrO2 on Ti, and TiO2 on Ti vs. uncoated CoCr surfaces
on day 5 of culture, indicating higher differentiation and mineralization by cells grown on these
nano-surfaces. Also, as shown by statistical analysis, the difference between nano-coated ZrO2 on
glass and CoCr was significant (p = .006).
Average gene expression levels for adhesion, assessed by PCR techniques, showed a
significant difference between nano surfaces ZrO2 on Ti vs. ZrO2 on glass (p = .05)., and also
between nano-ZrO2 on Ti vs. CoCr (p = .012). Average gene expression levels in the proliferation
experiments showed significant differences between nano-ZrO2 on Ti vs. CoCr (p = .021), and also
between nano-TiO2 on Ti vs. CoCr (p = .013). Average gene expression levels in the differentiation
experiments showed significant differences between nano-ZrO2 on Ti vs. CoCr (p = .005). In
addition, some individual genes, including EGFLAM, ALPL, SPP1, and SP7 and their ranks among
all other 7 genes at different experiments were studied separately (data are not shown). EGFLAM
was ranked 1 and 2 for nano-surfaces in adhesion, while it was 7 for CoCr. The rank numbers for
different surfaces were almost the same in the proliferation experiments (3, 4, and 5), but for the
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differentiation experiments, the ranks changed (rank 1, 2 and 5 for nano-surfaces and 7 for CoCr).
ALPL was almost the same for all the surfaces in the adhesion and proliferation experiments
(average of 2), while in the differentiation experiments, the ALPL rank was 6 and 7 for nanosurfaces and 1 for CoCr. SPP1 was ranked 5, 6, and 7 for nano-surfaces in adhesion experiments,
while it was 3 for CoCr. In the proliferation experiments, the rank was 1 and 2 for nano-surfaces
but 7 for CoCr. Moreover, for the differentiation experiments, the rank was 1, 2, and 3 for nanosurfaces and 6 for CoCr. SP7 was ranked 5, 6, and 7 for nano-surfaces in adhesion experiments,
while it was 3 for CoCr. In the proliferation experiments, the ranks were almost similar as in the
adhesion experiments (7 for nano-surfaces and 4 for CoCr). For differentiation experiments, the
ranks were different and became 1, 3, and 4 for nano-surfaces and 5 for CoCr.

DISCUSSION
The Ki-67 expression was 1.3, 1.7, and 1.2 fold higher for cells on nano-coated surfaces
ZrO2 on glass, ZrO2 on Ti, and TiO2 on Ti vs. uncoated CoCr surfaces at day 4 after plating, and an
independent samples t-test showed a P-value = .038 for Ki-67 expression differences of the cells
between nano-ZrO2 on Ti vs. CoCr. This result indicated that cells seeded on nano-coated surfaces
proliferated more and showed increased growth rates when compared with the uncoated control
CoCr surface. Also, among nano-surfaces, ZrO2 on Ti shared the significant difference with control
surface CoCr, suggesting that substrate used for coating may also play a role, along with the coated
material, and this needs further investigation. For this experiment, cells were harvested at 50%
confluency which was in the middle range confluency. Since we measured proliferative activity, it
was essential to harvest cells when they were in the log phase of growth, before they started
changing their gene expression patterns due to contact inhibition and nutrient limitations or became
quiescent. In the experiment at higher confluency (i.e., 70-80%), the fold changes between nano-
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surfaces and CoCr decreased, and significant differences between ZrO2 on Ti and CoCr were not
observed (data is not shown).
Since ZrO2 on glass had the lowest Ki-67 expression, it was selected to be compared with
uncoated CoCr, and both early and late apoptosis of SAOS-2 cells on uncoated CoCr and ZrO2
nano-coated glass surfaces showed significant differences. The viability percentage is a
combination of the survival of the cells on the surfaces and their death because of apoptosis as a
response to the surface. The differences in apoptosis obtained from the nano-surfaces with the
lowest proliferation activity indicated that survival of SAOS-2 cells is as0ciated with nano-coated
surfaces compared to the uncoated CoCr.
Osteoblastic differentiation measured by ALP activity is an indicator of the initial stages
of differentiation of osteoblast-like cells. The experiment was performed with different ALP
dilutions including 1 to 100 and 1 to 250. The data was consistent internally. However, the 1 to 250
dilution shows differences with higher fold changes, suggesting this dilution was optimal for the
standard curve (in the linear part of the curve). Normalization using BCA was also performed with
1 to 1 and 1 to 4 dilutions. The data was consistent from both dilutions, and the 1 to 1 dilution data
is presented here. ALP activity measured on day 5 of culture was 2.8, 1.5, and 1.4 -fold higher for
cells on nano-coated ZrO2 on the glass, ZrO2 on Ti, and TiO2 on Ti vs. uncoated CoCr surfaces. In
addition, as shown by statistical analyses, the differences between nano-coated ZrO2 on glass and
CoCr was significant (p = .006). Osteoblastic cells differentiate to produce bone. Therefore, in a
clinical setting, enhanced bone formation and mineralization would be expected from cells grown
on nano-crystalline surfaces compared to CoCr surfaces.
Taken together, the Ki-67 and ALP data suggest that nano-coatings can accelerate and
increase proliferation and differentiation of osteoblasts compared with uncoated CoCr surfaces.
However, it is clear that some nano-surfaces favor proliferation while others favor differentiation.

79
This fits the cell differentiation paradigm that well-differentiated cells proliferate at a lower rate
while less differentiated cells are highly proliferative (81).
Increasing the rate of growth, maturation, and mineralization leading to bone formation
could decrease healing time for patients, reduce the chance of systemic infection, and increase the
longevity of implants.
Overall, data from PCR experiments showed that for all adhesion, proliferation and
differentiation experiments, nano-surfaces are better than CoCr. Average gene expression levels
for adhesion showed that nano-coatings enhanced cell interactions with the surface and altered cell
behavior (specifically the difference between nano-ZrO2 on Ti vs. CoCr). Also, a significant
difference between nano surfaces ZrO2 on Ti vs. ZrO2 on glass was observed suggesting that in
adhesion experiments substrates that were used for nano-coatings also played a role. Therefore, the
differences between nano-surfaces and CoCr was a combination effect of nano-coatings and
substrate materials, and it was shown that Ti is a better substrate than glass. It also has been shown
that the natural micro-roughness of Ti and its oxides improve its biocompatibility (49) and this may
explain why Ti is a better substrate. However, to avoid the effects of any surface roughness, other
than the IBAD nano-roughness, our previous study was designed to use only smooth glass
substrates.
Similarly, differences in average gene expression levels for proliferation indicated that the
proliferation of SAOS-2 cells was more compatible with nano-coated surfaces, compared to the
CoCr. It also appears that only nano-coated surfaces on Ti substrates showed significant differences
with CoCr and this could be either effect of Ti substrate on proliferation genes, or having more
cells due to increased initial adhesion levels. Data for the proliferation marker (MKI-67) did not
show any difference among nano-surfaces. Therefore, the effect of the substrate on proliferation
appears small. In the differentiation experiments, differences between average gene expression
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levels for nano-coatings and CoCr were observed, while there was no difference between the Ti
and glass substrates.
In addition, some individual genes and their ranks among all other 7 genes were studied in
different experiments, in case any specific regulation could be observed among nano-surfaces vs.
CoCr. EGFLAM is FN that promotes initial cells attachments to surfaces and regulates their
migration during tissue differentiation. Therefore, its ranking should be highest in adhesion and
differentiation experiments. Indeed, it was ranked 1 and 2 for nano-surfaces in adhesion
experiments while it was 7 for CoCr, which fits with the higher level for cell attachments to the
nano-surfaces. For the proliferation experiments, the ranks showed no differences between different
surfaces (3, 4, and 5), but again for differentiation experiments, it was highest for nano-surfaces
(rank 1, 2 and 5) while CoCr showed no increase in transcribing this particular gene (rank 7 for
CoCr). ALPL is ALP gene, that is essential for bone mineralization, and it marks the initial stage
of differentiation. Its gene transcription starts from early stages and decreases later; therefore we
expected to see high ranks in the adhesion and proliferation experiments, but a lower rank for the
differentiation experiments. In the adhesion and proliferation experiments, the rank was almost the
same for all the surfaces (average of 2), but in later stages (differentiation experiments) ALPL
transcription was reduced for nano-surfaces (rank 6 and 7), but it was still high for CoCr (rank 1),
potentially indicating delayed differentiation of SAOS-2 cells on CoCr. SPP1 represents
osteopontin that is a marker for the middle stage of osteoblast differentiation. Based on the timing
of experiments, the increase in rank was expected in the proliferation and differentiation
experiments, but not in the adhesion experiments. Again, this pattern was observed among nanosurfaces (ranked 5, 6, and 7 in adhesion experiments, 1 and 2 in the proliferation experiments, and
1, 2, and 3 in the differentiation experiments) while SPP1 rank CoCr was 6. SP7 is Osterix, a critical
transcription factor in osteoblast differentiation. For nano-surfaces, its rank in adhesion was 5, 6,
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and 7, in the proliferation experiments 7, and for differentiation experiments, it became 1, 3, and 4.
For CoCr the rank was 3, 4, and 5 relatively. Taken together, it showed that cells on CoCr either
started differentiation very early or very late. If they started differentiation very early, it means they
were not very proliferative and could not cover the surface rapidly, and this could affect the healing
time. If the second alternative is the explanation and they started differentiation later, this could
delay the mineralization and the bone-forming process.
The results presented in this study indicate that nano-crystalline surfaces produced via the
IBAD technique improved adhesion, proliferation, and differentiation of SAOS-2 bone-forming
cells in vitro compared with the same cells growing on uncoated CoCr surfaces, by altering their
gene expression profiles. This indicates the biocompatibility of the nano-coatings produced by
IBAD technique, along with their other known properties, such as wettability and hardness makes
them promising candidates for osseointegration applications (22). However, additional studies
including in vivo experiments using animal models, are needed to understand the behavior of these
materials in more detail, in particular, their interactions with the in vivo environment, e.g., corrosion
and potential toxicities, although there is, currently, no evidence that these will be issues.
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CHAPTER SIX: DISCUSSION

GENERAL DISCUSSION AND SUMMARY
It has been shown that the selection of implant biomaterials directly impacts the
effectiveness and success of TJR. One of the crucial factors that influence this selection is material
properties and biocompatibility (79). Osseointegration is determined by the design, chemical
composition, surface topography, and coating of the implants (69), and many studies have been
conducted to investigate the effect of surface modifications on the TJR outcomes. Although some
data are available from animal models, most of these studies have been limited to in vitro
experiments. Unfortunately, there are no standardized in vitro methods being utilized for assessing
the new surfaces in TJR. Thus, the present study developed and described standard methods to
establish a model system that may be extended to other studies. After a comprehensive search to
evaluate a proper model for osteoblast functions, we decided on the use of the SAOS-2 cell line. In
addition, we developed experiments to investigate many of the essential cellular events including
adhesion, proliferation, cell morphology, apoptosis, and differentiation. Moreover, experiments
were devised to compare different nano-samples and different control samples, including noncoated, polished metallic surfaces to investigate the impact of nano-coatings along with the effect
of coatings’ chemistry and substrates on outcomes. Furthermore, during preliminary optimization
studies, we identified the optimized timing for experiments, cell seeding densities, appropriate cell
detachment agents, volumes and timing as well as appropriate surface cleaning methods.
Our first series of studies “Compared Biocompatibility of Nano-Crystalline Titanium and
Titanium-Oxide with Micro-Crystalline Titanium” (chapter 3), which evaluated adhesion,
morphology, and differentiation of SAOS-2 cells on those surfaces. The adhesion experiment
showed a higher number of cells on nano-structured surfaces compared to biomedical grade Ti,
which indicated more adhesion and growth on nano-surfaces. Besides DAPI staining, actin fiber
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shapes were monitored and a significant difference in cell shape was observed on nano-crystalline
TiO2 and Ti (large focal adhesions) compared to micro-crystalline Ti (thin and round shapes). The
alizarin red assay for observing calcium deposition of SAOS-2 cells showed that the cells cultured
on the nano-surfaces had a higher degree of differentiation. Therefore, enhanced bone formation
ability was expected from those surfaces. These were important observations that showed nanostructured surfaces possess unique properties that alter cell adhesion, growth, and differentiation
by direct (cell–surface interaction) mechanisms. However, we did not observe the effects of
substrates’ roughness and coatings’ chemistry on cell–surface interactions. Also, preliminary data
showed that the timing for adhesion and morphology experiments was best accomplished at 48
hours. In this period, adhesion and growth occurred consecutively, and thus there was no chance to
identify the effect of surfaces on initial adhesion.
Therefore, we designed a new series of experiments (adhesion, proliferation, metabolic
activity, and differentiation) for a new study “The Effects of Nano-engineered Surfaces on
Osteoblast Adhesion, Growth, Differentiation, and Apoptosis” (chapter 4). Previously, it has been
shown that the natural micro-roughness of Ti and its oxides improve its biocompatibility (49). Thus
in this study, we included nano-coatings of ZrO2 on glass compared to glass substrates to avoid the
effect of any surface properties other than the nano-roughness. Using smooth glass substrates
instead of Ti with inherent roughness, made it possible for us to isolate the specific effects of the
nano-roughness produced by the IBAD technique from other factors that might influence cell
interactions with surfaces. The outcomes were consistent with the previous study, and we showed
that adhesion and proliferation of SAOS-2 cells were greater on nano-ZrO2 compared with
uncoated glass surfaces, indicating that nano-coatings enhanced cell interactions with the surface.
Moreover, cells showed a more uniform distribution on nano-ZrO2 compared with uncoated glass
surfaces where they formed clumps to maintain viability, which indicated cell adhesion was more
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compatible with the nano-coated surface. The metabolic activity using the MTS assays showed
significantly higher levels for cells on nano-ZrO2 as compared to uncoated glass surfaces, indicating
increased growth rates for cells on those surfaces. Calcium deposition assessed by alizarin red
staining, an indicator of late differentiation and bone formation capability, was higher for cells on
nano-ZrO2 vs. uncoated glass surfaces. Thus, enhanced bone formation would be expected from
cells grown on those surfaces. The findings of this study showed that unique properties of IBADproduced nano-films increased surface biocompatibility, although only a specific nano-coating
(ZrO2) was studied and the effects of other coatings’ chemistry was not examined. Despite the fact
that essential cellular events were investigated in this study, none of them were evaluated at the
molecular level. Thus, further studies were planned to evaluate the mechanisms behind the
outcomes of the current study.
In the next study, “Surface Nano-Modification by Ion Beam Assisted Deposition Alters
the Expression of Osteogenic Genes in Osteoblasts” (chapter 5), the effects of IBAD-produced
nano-structured surfaces on SAOS-2 cells at the molecular level (investigated by assays of
adhesion, proliferation, differentiation, and apoptosis) and gene expression level (assessed by PCR
techniques at initial cell adhesion, proliferation, and differentiation) were evaluated. To imitate a
realistic scenario, the control surfaces were chosen to be orthopaedic grade CoCr. In this study, we
also extended our observations to a comparison between different surface coatings’ chemistry
(ZrO2 and TiO2) and different substrates’ roughness (glass and Ti). The proliferation of SAOS-2
cells assessed by nuclear cell proliferation-associated antigen Ki-67 was higher for cells on nanocoated surfaces vs. uncoated CoCr surfaces indicating higher proliferation and increased growth
rates on those surfaces. Since nano-ZrO2 on Ti only showed a significant difference with control
surface CoCr, the substrate used for coating may play a role, along with the coated material. Since
nano-ZrO2 on glass had the lowest Ki-67 expression, it was selected to be used for apoptosis
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experiments. Programmed cell death of SAOS-2 cells assessed by annexin V kit with PI staining
showed significant differences between uncoated CoCr and nano-ZrO2 surfaces in both early
apoptosis and late apoptosis, suggesting that differential toxicities of the surfaces and cellular stress
induced by them, were associated with survival. Osteoblastic differentiation, measured by ALP
activity, was higher for cells on nano-surfaces vs. uncoated CoCr surfaces, indicating higher
differentiation and mineralization by cells grown on those surfaces. Taken together, the Ki-67 and
ALP data suggested that nano-coatings can accelerate and increase proliferation and differentiation
of osteoblasts, compared with uncoated CoCr surfaces. However, it is clear that some nano-surfaces
favor proliferation while others favor differentiation, indicating the effect of coatings’ chemistry
on these cellular events. Since CoCr is mainly employed for articular components of the prosthesis,
its properties are consistent with such use.
Gene expression experiments assessed by PCR techniques were performed at initial cell
adhesion, proliferation, and differentiation levels. Overall, data from PCR experiments showed that
for all adhesion, proliferation, and differentiation experiments, nano-surfaces were better than
CoCr. Average gene expression levels for adhesion showed that nano-coatings enhanced cell
interactions with the surface and altered cell behavior. Also, a significant difference between nanoZrO2 on Ti vs. nano-ZrO2 on glass suggested that substrates used for nano-coatings played a role
in adhesion. Therefore, the differences between nano-surfaces and CoCr appears to have a
combination effect due to nano-coatings and substrate materials. Clearly, Ti was shown to be a
better substrate than glass, which may be due to the natural micro-roughness of Ti and its oxides.
Similarly, differences in average gene expression levels for proliferation indicated that the
proliferation of SAOS-2 cells was more compatible with nano-coated surfaces, compared to CoCr.
It also appears that only nano-coated surfaces on Ti substrates showed significant differences with
CoCr. This could be due to either the effect of Ti substrate on proliferation genes, or having more
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cells due to increased initial adhesion levels, or both. Data for the proliferation marker (MKI-67)
did not show any difference among nano-surfaces. Therefore, the effect of the substrate on
proliferation appears small or negligible. In the differentiation experiments, differences between
average gene expression levels for nano-coatings and CoCr were observed, while there was no
difference between the Ti and glass substrates.
Evaluating some individual genes and their ranks among the other 7 genes in different
experiments indicated interesting differences among nano-surfaces vs. CoCr. EGFLAM is FN that
promotes initial cell attachments to surfaces and regulates their migration during tissue
differentiation. Therefore, its ranking should be highest in adhesion and differentiation
experiments. Indeed, this was the case for nano-surfaces, but not for CoCr, which fits with the
higher level of cell attachments to nano-surfaces. ALPL is ALP gene, which is essential for bone
mineralization and marks the initial stage of differentiation. ALPL gene transcription begins from
early stages and decreases later; therefore we expected to see high ranks in the adhesion and
proliferation experiments, but a lower rank for the differentiation experiments. In the adhesion and
proliferation experiments, the rank was almost the same for all the surfaces, but in differentiation
experiments ALPL transcription was reduced for nano-surfaces and stayed high for CoCr,
potentially indicating a delayed differentiation of SAOS-2 cells on CoCr. SPP1 represents
osteopontin that is a marker for the middle stage of osteoblast differentiation. Based on the timing
of experiments, the increase in rank was expected in the proliferation and differentiation
experiments, but not in the adhesion experiments. This pattern was observed among nano-surfaces
but not for CoCr. SP7 is Osterix, which is a critical transcription factor in osteoblast differentiation
and was expected to rank high in differentiation experiments; this was true for nano-surfaces, but
not for CoCr. Putting together the observation from SPP1 and SP7, showed that cells on CoCr
either started differentiation very early or very late. If they started differentiation very early, it
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means they were not very proliferative and could not cover the surface rapidly, and this could affect
(delay) the healing time. If the alternative is the explanation and they started differentiation later,
this could delay mineralization and thus bone-forming processes.
All the outcomes presented here from the studies were internally consistent with each other
and indicated that nano-crystalline surfaces produced via the IBAD technique improved adhesion,
proliferation, and differentiation of SAOS-2 bone-forming cells in vitro compared with the same
cells growing on uncoated surfaces, by altering their gene expression profiles.

FUTURE DIRECTIONS
From our studies, we reported that surface modifications using the IBAD technique
enhanced biocompatibility of SAOS-2 osteosarcoma (osteoblast) cells. However, additional studies
in the future are needed to understand the behavior of these materials in more detail and to address
questions raised by our studies. Some of the possible future studies are discussed below:
1. In PCR studies, we evaluated the differences between surfaces based on 3 different time
course events. These timings were chosen based on previous studies and preliminary
data. However, it is likely that because this timeline was used, some changes might have
been missed or incompletely characterized. Further time-dependent studies are needed to
address these questions.

2. We observed the differences between surfaces in gene expression profiles and molecular
level. Except for actin staining, we did not characterize proteins localizations. It is
possible that some proteins produced by cells were not localized in the appropriate place
and thus may not be functional. Future studies should characterize both proteins
translation and localizations.
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3. There were significant differences between nano-coated surfaces and uncoated surfaces
which made nano-surfaces appears to be the better option for the bone contact component
of future implants. However, this observation raises the question as to whether nanosurfaces are still superior when they are compared to other modified surfaces. This
question can be addressed in future studies involving several modified surfaces besides
control surfaces.

4. We analyzed the expression profile of limited genes to understand the biologic
differences that were observed on different surfaces at the genetic levels. These genes
were selected based on preliminary data and other studies in the literature. To conduct a
more comprehensive study, RNA seq or microarray would make a more complete
characterization of molecular differences. However, they are currently beyond the scope
of this dissertation.

5. Since interactions with foreign bodies are very complicated, these promising in vitro
results presented here are the first step in the further testing of IBAD-modified surfaces in
animal models for potential future use for human implants.

6. Although the IBAD-modified surfaces are believed to possess enhanced corrosion
resistance, future studies are needed to test whether they release toxic metallic ions into
the body as they become oxidized, which can lead to immune reactions and implant
degradation.

7. Many studies have been shown that bacterial coverage increases on different surfaces as
roughness increases (82). However, roughness parameters do not have equal effects on
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this promoted coverage, and sometimes different parameters or variant topography lead
to biofilm inhibition. Potential future studies can determine how IBAD- modification
affects bacterial adhesion and outcomes.
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APPENDIX A: PRELIMINARY DATA
1. Cell detachment methods
This experiment was aimed to compare different cell detachment methods to figure out
which method affected the cells viability less in an optimized time frame. In this regard, 3 different
known detergents were used.
Trypsin: Trypsin is the most common treatment to remove adherent cells from a culture surface.
In this experiment, 1X Trypsin solutions 0.025% was used to avoid any damages to cell
membranes.
Accutase: Accutase is another cell dissociation used for the routine detachment of cells from
standard tissue culture. Compared to trypsin, accutase maintains higher cell viability following
detachment of cells.
Cellstripper: Cellstripper is a non-enzymatic cell dissociation solution that gently detaches
adherent cells in culture. Cells can be exposed to cellstripper for extended periods of time without
the risk of damage associated with protein-digestive enzymes like trypsin.
To measure the detached cells’ viability, a live/dead fixable stains kit was used. Using flow
cytometry, this kit assessed cell viability in samples via the reaction of fluorescent reactive dyes
with amines (cellular proteins). These dyes cannot penetrate live cell membranes and only react to
cell surface proteins resulting in faint staining. However, the dyes can permeate the damaged
membranes of dead cells and stain both the interior and exterior amines, resulting in intense
staining. Therefore, the difference in fluorescence intensity discriminated between the live and dead
cells.
In this regard, 3 flasks of cells were collected at 50% confluency. After aspirating medium
and washing with 2 ml PBS, 1 ml of trypsin, accutase, or cellstripper was added to each flask.
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Incubated for 2 minutes, 10 minutes, and 25 minutes relatively (these timings were when half of
the cells were detached, checked using a microscope), 5 ml of medium were added to each flask,
cells were filtered, counted, and centrifuge at 300 rpm for 5 minutes. Cells were resuspended in 2
ml of PBS for experiment and in 2 ml of PBS for control. Dyes were prepared based on the
manufactural protocol, 1 μL of which were added to 1 mL of the cell suspension, mixed well, and
incubated in room temperature in the dark for 30 minutes. Cells were washed twice with 1 mL of
PBS with 1% BSA, resuspended in 1 mL of PBS with 1% BSA and were analyzed by flow
cytometry using the appropriate detection channel (450/50 nm or similar).

Figure A-1: Percentage of viable cells detached by trypsin measured by flow cytometry
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Figure A-2: Percentage of viable cells detached by accutase measured by flow cytometry

Figure 0A-3: Percentage of viable cells detached by cellstripper measured by flow cytometry
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The result showed more dead/damaged cells detached by trypsin while accutase method
showed the least dead cells and debris (highest viability percentage). In addition, cellstripper was
not a viable option, since time was an important factor and 20 minutes seemed to be too long.

2. Accutase timing
After choosing accutase to be the detachment detergent, the next step was to find the
optimal timing for cells’ detachment with the least amount of damage and the highest viability.
This experiment was done using glass samples (actual size). In this regard, 10 flasks of cells were
harvested at 50% confluency using trypsin, detached cells were adjusted to 500,000 cells per ml, 8
samples were placed in a 12-well plate, and each sample was seeded with 500,000 cells. After 24
hours incubation, samples were transferred to a fresh 12-well plate, and 1 ml fresh medium was
added and incubated for another 24 hours. After aspirating medium, samples were washed with 0.5
ml PBS, 300 µl of accutase were added to each sample, and samples were incubated for 5 minutes,
10 minutes, 15 minutes, and 30 minutes in duplicates. Detached cells were put in 4 separate 15-ml
conical tubes, and the other 4 samples were fixed and stained with DAPI, and counted as described
in previous methods. Detached cells were filtered, counted, and centrifuge at 300 rpm for 10
minutes. Cells were resuspended in 0.5 ml of PBS for experiment and in 0.5 ml of PBS for control.
Prepared based on the manufactural protocol, 1 μ of dyes was added to 1 mL of the cell suspension,
mixed well, and incubated in room temperature in the dark for 30 minutes. Cells were washed twice
with 1 mL of PBS with 1% BSA, resuspended in 1 mL of PBS with 1% BSA, and were analyzed
by flow cytometry using the appropriate detection channel (450/50 nm or similar).
The results from flow cytometry indicated that 10 minutes had the highest amount of
harvested cells with highest viability percentage. Therefore, the 10-minutes incubation time was
chosen to be the optimal timing for the accutase detaching method.
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Figure A-4: Detached cells using accutase after 5 minutes incubation time

Figure A-5: Detached cells using accutase after 10 minutes incubation time

103

Figure A-6: Detached cells using accutase after 15 minutes incubation time

Figure A-7: Detached cells using accutase after 30 minutes incubation time

104
3. Cleaning detergents
Due to a shortage of nano-samples, some samples had to be reused for a limited number
of experiments. In order to find the best detergent to clean proteins and residuals on used samples,
without interfering with surface properties, liquinox and tergazyme were chosen.
Liquinox: it is an FDA certified cleaning liquid detergent with a wide application range
from healthcare instruments to industrial parts. It is phosphate free, biodegradable, with a corrosion
inhibited formulation that leaves no interfering residues.
Tergazyme: it is an FDA certified enzyme-active powdered detergent with a wide
application range from healthcare instruments to industrial parts. It is biodegradable, with a
corrosion inhibited formulation that leaves no interfering residues, and contains protease enzyme
to remove proteinaceous.
To test the toxicity of these detergents, apoptosis experiment (as explained previously) was
performed using the fresh ZrO2 sample, used-ZrO2 sample washed with liquinox, used-ZrO2 sample
washed with tergazyme, and used-ZrO2 sample without any detergent wash. The data showed no
significant differences between the fresh sample and detergent-washed samples. Although, liquinox
seemed to be more similar to the fresh samples. Therefore liquinox has been selected as a cleaning
detergent for reusing samples if it is necessary.

